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Abstract
In Finland breast reconstruction is performed 
for about –   of women operated on for 
breast cancer. A popular method for creating a 
new breast is the transverse rectus abdominis 
musculocutaneous (TRAM) fl ap formed solely 
of the patient’s own tissue from the lower ab-
dominal area. Th e fl ap can be raised as a pedi-
cled or a free fl ap. Th e pedicled TRAM fl ap, 
based on its nondominant pedicle superior 
epigastric artery (SEA), is rotated to the chest 
so that blood fl ow through SEA continues. 
Th e free TRAM fl ap, based on the dominant 
pedicle deep inferior epigastric artery (DIEA), 
is detached from the abdomen, transferred to 
the chest, and DIEA and vein are anastomosed 
to recipient vessels on the chest. Cutaneous ne-
crosis is seen in –   of the pedicled TRAM 
fl aps and in –   of free TRAM fl aps. 
Th e aim of this study was to measure 
changes in cutaneous blood fl ow on the ipsilat-
eral (over the rectus muscle) and contralateral 
(opposite side) sides of the fl ap with laser Dop-
pler fl owmetry (LDF) and transcutaneous oxy-
gen tension (PtcO) at diff erent phases before, 
during and aft er breast reconstruction with 
pedicled (I) and free (II) TRAM fl aps, and to 
predict development of necrosis in pedicled 
TRAM fl aps. Th e role of plasma endothelin- 
(ET-), a powerful vasoconstrictor secreted 
by vascular endothelial cells, in cutaneous ne-
crosis of fl aps and the peripheral vasoconstric-
tion observed aft er long operations (III), and 
the eff ect of felodipine, a vasodilating calcium 
antagonist, on those parameters (IV) were also 
studied. One aim was to study the association 
of cutaneous or fat necrosis and the amount of 
obesity of the patient, using body mass index 
(BMI), waist-hip circumference ratio (WHCR) 
and thickness of subcutaneous abdominal fat 
as indices of obesity (V).
Th is thesis consists of fi ve prospective stud-
ies (I–V) performed in altogether  women, 
ten of whom took part in studies III and V. In 
 pedicled TRAM fl aps (I), elevation of the 
contralateral side of the fl ap caused an increase 
in cutaneous blood fl ow on the ipsilateral side 
of the fl ap compared to the measurements 
taken aft er induction of anesthesia. A possible 
cause for the hyperemia may be opening up of 
the “choke” vessels interconnecting adjacent 
vascular areas, angiosomes. Ligation of DIEA 
caused a signifi cant decrease of LDF levels on 
the contralateral skin, lasting until the fi rst 
postoperative day. Th e contralateral PtcO de-
creased from the initial  ±  mmHg to  ±  
mmHg when DIEA was cut and stayed low on 
the operation day. It increased slowly during 
the postoperative week. Th e LDF and PtcO lev-
els were lower on the contralateral than ipsilat-
eral side of the fl ap at all measuring times. SEA 
apparently cannot perfuse the pedicled TRAM 
fl ap suffi  ciently on the operation day.
In ten free TRAM fl aps (II), elevation of the 
contralateral side caused a similar hyperemia 
as in pedicled fl aps. Interruption of blood fl ow 
before performing the anastomoses was seen 
as a decrease of LDF levels. LDF levels and 
the ipsilateral PtcO returned to the base line 
levels in the recovery room, as as did the con-
tralateral PtcO on the third postoperative day. 
Compared with the pedicled fl aps in study I, 
the postoperative blood fl ow in the free TRAM 
fl ap seems generous. 
Cutaneous necrosis was observed in eight 
(  ) of the  pedicled TRAM fl aps (I). Th e 
development of cutaneous necrosis could be 
predicted based on intraoperative LDF measure-
ments. Th e contralateral LDF level decreased 
aft er ligation of the DIEA to a lower level in 
fl aps developing necrosis ( +    of the initial 
value) compared to fl aps healing uneventfully 
( +   , p < ). Cutaneous necrosis cannot 
be predicted based on the intraoperative PtcO 
values. Th e contralateral PtcO was signifi cantly 
lower in the recovery room and on the postop-
erative days in fl aps developing necrosis (I).
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In study III, plasma ET- concentrations 
were elevated preoperatively, . (.–.) 
pg/ml (median, – quartiles), near  pg/
ml during the operation, and around  pg/ml 
during the postoperative recovery room period 
of three hours in nine patients with a pedicled 
TRAM fl ap. Temperature gradient (Tgrad, the 
diff erence between skin temperatures of the an-
tebrachium and index fi nger) indicated periph-
eral vasoconstriction preoperatively and post-
operatively. A statistically signifi cant nonlinear 
correlation was found in the nonparametric 
Spearman rank correlation test between ET- 
and Tgrad (r = ., p < .), and ET- and mean 
arterial pressure (MAP) (r = ., p < .), but 
not between ET- or Tgrad and development of 
necrosis, and ET- and heart rate (HR). ET- 
may play a role in postoperative peripheral va-
soconstriction aft er long operations (III).
Oral felodipine ( mg) administered on the 
preoperative evening and on the operation 
morning, caused no diff erences in periopera-
tive plasma ET- concentrations, Tgrad, post-
operative PtcO, or development of cutaneous 
necrosis of free TRAM fl aps between the felo-
dipine group (n = ) and the control group 
(n = ) in a placebo-controlled randomized 
study. An increase of HR was seen in felodipine 
patients. (IV). 
Cutaneous or fat necrosis was observed in 
two of the fi ve overweight patients (BMI > ), 
in three of the six patients of ideal weight, but 
not in the one underweight patient (BMI < ). 
None of the  patients were obese (BMI > ). 
Four of the six patients with lower body type 
fat distribution (WHCR < ,), none of the 
four patients with upper body type fat distribu-
tion and one of the two patients with WHCR 
,–, developed necrosis. Th ere were 
no diff erences in the thickness of subcutane-
ous fat in patients with and without necrosis. 
Neither BMI nor the thickness of abdominal 
subcutaneous fat seems to be associated with 
the development of cutaneous or fat necrosis in 
pedicled TRAM fl aps. An association may exist 
between lower body type fat distribution and 
development of marginal necrosis in pedicled 
TRAM fl aps (V). 
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PaO arterial oxygen tension
PtcO transcutaneous oxygen tension
SD standard deviation
SEA superior epigastric artery
SEM standard error of mean
SIEA superfi cial inferior epigastric artery
Tant temperature of antebrachium skin
Tgrad temperature gradient (Tant–Tind)
Tind temperature of index fi nger
Tperiph peripheral temperature
Trect rectal temperature
TAP thoracodorsal artery perforator
TRAM transverse rectus abdominis 
musculocutaneous
WHCR waist-hip circumference ratio
WHO  World Health Organization
ACE angiotensin-converting enzyme
BCT breast-conserving therapy
BMI body mass index (kg /m)
CI confi dence interval
DBR  delayed breast reconstruction 
DCIS ductal carcinoma in situ
DIEP deep inferior epigastric perforator
ET endothelin
ET- endothelin-
GAP gluteal artery perforator
HR heart rate
IBR  immediate breast reconstruction
LCIS lobular carcinoma in situ
LD latissimus dorsi
LDF laser Doppler fl owmetry
LDPI laser Doppler perfusion imaging
MAP mean arterial pressure
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Breast cancer is the most common cancer in 
women. In –, it was diagnosed an-
nually in  women per   in Finland, 
in  in  women, and by the year  
the fi gure is expected to reach  (Finnish 
Cancer Registry ). Despite the increasing 
incidence, the prognosis has improved during 
the last couple of decades, with approximately 
   of the patients being alive fi ve years aft er 
the diagnosis (Finnish Cancer Organizations 
). 
Chemotherapy and radiation therapy along 
with surgery, either conserving or radical, form 
the cornerstone of breast cancer treatment 
(National Cancer Institute a). Mastectomy 
is performed in about half of patients. In pa-
tients undergoing mastectomy, disturbances in 
body image and problems with the exogenous 
prosthesis can lead to a variety of psychological 
problems, physical symptoms, and diffi  culties 
in social life. Nowadays, either immediate or 
delayed breast reconstruction with an artifi cial 
implant or autologous tissue is off ered in many 
cases to improve the quality of life (Blamey 
, Newman , Piasecki ). 
Th e disadvantages related to the prosthesis 
can be avoided, and the esthetic result is oft en 
considered better with breast reconstruction 
using autologous tissue. Transplantation of 
either a pedicled or a free transverse rectus 
abdominis musculocutaneous (TRAM) fl ap 
for breast reconstruction was introduced some 
 years ago (Robbins , Holmström , 
Hartrampf ). Th e breast created with the 
TRAM fl ap is soft  and natural-looking com-
pared to other methods. Regardless of the 
popularity of the TRAM fl ap, complications 
related to the fl ap circulation still occur. 
To overcome the technical obstacles of 
breast reconstruction, it is of the utmost im-
portance to understand the changes in cuta-
neous blood fl ow of the fl aps during and aft er 
surgery. Vasoconstriction can compromise the 
viability of the fl ap. During operations of long 
duration, imminent hypothermia results in 
decreased cutaneous blood fl ow. An important 
mediator in vasoconstriction is endothelin, 
ET-, a peptide secreted by vascular endothe-
lial cells (Yanagisawa ). High ET- levels 
have been measured in ischemic experimental 
fl aps (Matsuzaki ). Th e untoward eff ects 
can be antagonized with such drugs as calcium 
antagonists, which have been shown to sup-
press ET- release (Kiowsky , Liu ) 
and also to enhance the survival of experimen-
tal skin fl aps (Yessenow , Davis ). 
Overweight of the patient may pose a risk 
to the viability of the TRAM fl ap. Th e probable 
underlying causes are vascular problems (Lapi-
dus ) and the stretch caused by the heavy 
fl ap on musculocutaneous perforator vessels 
nourishing the fl ap (Schefl an ). Conse-
quently, obesity has been considered a rela-
tive contraindication to breast reconstruction 
by some authors (Schefl an a, Hartrampf 
, Grotting ). However, the eff ects of 
the type of body fat distribution and the thick-
ness of abdominal subcutaneous fat on survival 
of the fl ap skin are unknown. 
Th is thesis was designed to evaluate the 
changes in cutaneous blood fl ow in the TRAM 
fl aps and to study the eff ects of a calcium an-
tagonist, felodipine, on plasma endothelin 
concentrations and fl ap survival. Moreover, 






Breast cancer is the most common malignant 
tumor in women in Finland, accounting for 
   of all female cancer cases. Th e incidence 
of breast cancer has been increasing since 
the s. It was diagnosed in Finland annu-
ally in  women during –, repre-
senting  per   women, and in  
women in , representing  per   
women (Finnish Cancer Registry ). Th e 
incidence is at the same level in all Western 
countries (Mäkelä ). Th e probable causes 
of the increase are trends towards obesity, 
changes in reproductive patterns, and the use 
of postmenopausal hormone replacement 
therapy (American Cancer Society ). 
Th anks to better diagnostics by mammog-
raphy, more cancer cases are observed at an 
early stage. According to the latest trends in 
Finland,  of the   new cancer cases 
diagnosed in  in women are expected to 
be breast cancer cases (Finnish Cancer Orga-
nizations ). 
Every tenth woman living until the age of 
 years has been calculated to get breast can-
cer during their lifetime. Very few cases occur 
in women younger than  years. In Finland, 
about    of cases are diagnosed in the age 
group – years,    in the age group –
 years, and    in patients aged  years or 
over (Finnish Cancer Registry ). Th e inci-
dence increases with advancing age. In USA, 
in women aged – years the incidence rate 
was low, . cases per  , while the cor-
responding rate was  per   in women 
aged – during – (American 
Cancer Society ).
2.1.2. Manifestations 
Th e female breast consists of – lobules at-
tached by connective tissue and fat. Th e lobules 
are connected by small ducti (World Health 
Organization , American Joint Com-
mittee of Cancer , Finnish Current Care 
Guidelines ).
Th e most common form of breast cancer is 
ductal carcinoma. It occurs as an invasive form 
or as ductal carcinoma in situ (DCIS). Th e 
ductal invasive carcinoma represents –   
of all invasive breast cancers. DCIS is an early, 
precancerous condition, where the cancer cells 
have not invaded the breast tissue, but remain 
inside the ducti. DCIS usually remains lo-
cal, but may sometimes progress to invasive 
cancer. Th e incidence of DCIS has increased 
considerably because of increased detection by 
mammography. In USA, DCIS accounted for 
   of all breast cancers diagnosed in  and 
   in  (Page , Ernster ). Th e 
less common lobular carcinoma (–   of 
all breast cancers) originates from the lobules 
and is oft en bilateral. Lobular carcinoma in situ 
(LCIS) also exists; it is not considered malig-
nant, but is a risk factor for breast cancer. It is 
usually multicentric and frequently bilateral. 
Paget’s disease is a form of breast cancer mani-
festing as eczema of the nipple. In histological 
examination, intraepidermal carcinoma cells, 
DCIS changes, and sometimes invasive growth 
are observed. Th ere are also some less common 
cancer types, e.g. tubular, mucinous, papillary, 
scirrhous, and infl ammatory breast cancers 
(National Cancer Institute a).
2.1.3. Treatment
Treatment of breast cancer should be tailored 
individually for each patient. Breast cancer is 
commonly treated by various combinations 
of surgery, radiation therapy, chemotherapy, 
2 Review of the literature
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hormone therapy, and monoclonal antibody 
therapy. It is a multidisciplinary team approach, 
involving specialists in surgery, radiology, pa-
thology, oncology, nuclear medicine, plastic 
surgery, and anesthesiology. Selection of ther-
apy may be infl uenced by the age, menopausal 
status, general condition and opinion of the pa-
tient, stage of the disease, histologic and nuclear 
grade of the primary tumor, estrogen-receptor 
and progesterone-receptor status, measures of 
proliferative capacity, and HER/neu gene am-
plifi cation (Finnish Current Care Guidelines 
, National Cancer Institute a). 
Th e basic objectives of the treatment are 
to remove the tumor from the breast and the 
metastases from the axilla, nowadays with the 
help of sentinel node biopsy, and to minimize 
the recurrence of the cancer locally and in the 
axilla. Selection of the surgical method is based 
on the pTNM classifi cation and staging of the 
tumor (American Joint Committee of Cancer 
, Finnish Current Care Guidelines ). 
Th e operation methods used are mastectomy 
or breast-conserving therapy (BCT). Simple 
or total mastectomy includes removal of the 
entire breast. In modifi ed radical mastectomy, 
also the lymph nodes in the axilla are removed. 
Radical mastectomy, including also removal 
of the underlying chest wall muscle, is rarely 
used today because of proven eff ectiviness of 
the less disfi guring surgeries (Veronesi ). 
Th e indications for mastectomy are shown in 
Table I (Finnish Current Care Guidelines , 
National Cancer Institute a). 
During the last ten years, skin-sparing 
mastectomy has become popular. It involves 
removal of the nipple/areolar complex and 
preserving the breast´s skin envelope (Sim-
mons ). It is considered safe in selected 
T/T tumors (Toth , Cunnick ). In 
BCT, the tumor is removed by lumpectomy, 
quadrantectomy, or segmental mastectomy. 
Nowadays in Finland, BCT is used in –   
of breast cancer operations. Mastectomy is per-
formed for –   of the women, i. e. –
 women yearly (Stakes ). Th e most 
important prognostic marker in breast cancer 
is the status of the axillary lymph nodes (Fisher 
, Morrow ). Th e use of sentinel node 
biopsy has decreased the need for unnecessary 
axillary evacuations, which can cause sequelae 
for the patient (Ververs ), and scarring or 
damage of the vessels used as recipients in mi-
crovascular breast reconstruction. Th e lymph 
node nearest the site of the primary cancer, 
receiving the lymph drainage directly from 
the tumor, is regarded as the sentinel node, the 
most likely site of early metastases (Morton 
). In this procedure technetium-labeled 
sulfur colloid solution, vital blue dye, or both 
are injected around the tumor or biopsy cavity 
preoperatively, and the lymph node or nodes 
fi rst activated by the marker solution or the dye 
(sentinel nodes) are removed for histological 
examination as a frozen section analysis. If the 
sentinel nodes are free of cancer, the axilla is 
left  intact. If a metastasis is found, and in rare 
cases where sentinel nodes are not found, the 
axilla is evacuated in the same operation. Short 
follow-up studies have revealed hardly any 
axillary recurrence in patients who were left  
without axillary evacuation because of negative 
sentinel nodes (Schrenk , Chung , 
Guenther , Veronesi , Leikola ). 
However, no long-term follow-up studies exist 
on sentinel node biopsy since it has only been 
in use from the end of the s onwards. In 
Finland, it has been in use since . 
Th e local recurrence rate is increased in 
BCT compared with mastectomy in patients 
Table I. Indications for mastectomy.
1. Tumor is large compared with the size of the breast, and neoadjuvant therapy is not planned.
2. Cases with multiple areas of cancer far from each other in the breast.
3. Infl ammatory breast cancer after chemotherapy.
4. Cases where wound margins free of cancer cannot be produced by breast conserving therapy.
5. Cases where the adjuvant therapy being planned cannot be given.
6. The patient wishes mastectomy to be performed.
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not receiving radiation therapy (Cutuli ). 
Adding radiation therapy to the regimen aft er 
BCT increases long-term survival to the same 
level as in patients with mastectomy (Cutuli 
). Radiation therapy is used to reduce the 
size of the tumor or metastases before surgery 
or to destroy cancer cells remaining in the 
breast, chest wall, or axilla aft er surgery (Early 
Breast Cancer Trialists’ Collaborative Group 
). Most patients with DCIS can be treated 
with BCT with or without radiation therapy. 
Tamoxifen may decrease local invasive recur-
rence in DCIS, but it has no eff ect on survival 
(Fisher ). Th e side-eff ects of tamoxifen 
include an increased risk of thrombotic events 
and endometrial cancer (Fisher ). It is not 
recommended in routine therapy, but some 
patient groups may benefi t from it (Finnish 
Current Care Guidelines , National Can-
cer Institute a). 
All histologic types of invasive breast can-
cer may be treated with BCT and radiation 
therapy (Weiss ). In patients without dis-
tant metastases (stages I–III A + operable III C 
patients) (American Joint Committee of Can-
cer ), options for surgical management of 
the primary tumor include BCT plus radiation 
therapy, mastectomy plus reconstruction, and 
mastectomy alone. Survival is equivalent with 
any of these options, as documented in ran-
domized prospective trials (Jacobson , 
Veronesi , van Dongen , Veronesi 
).
Most women with LCIS can be managed 
without additional local therapy aft er biopsy. 
No evidence indicates that re-excision to ob-
tain clear margins is required. Tamoxifen has 
decreased the risk of developing breast cancer 
in women with LCIS (Fisher ). It is includ-
ed in the therapy guidelines of LCIS patients in 
USA (National Cancer Institute a), but in 
Finland it is not routinely used in this patient 
group (Finnish Current Care Guidelines ). 
At present there is no curative treatment for 
disseminated breast cancer, but the quality of 
life can be improved and the disease-free and 
total survival increased with systemic therapy. 
Breast cancer metastases are frequently osseal, 
but they are oft en found also in the liver, brain, 
lungs, and other soft  tissues. Systemic therapy 
includes chemotherapy, hormone therapy, and 
biological therapy. 
Systemic treatment can be given preop-
eratively as neoadjuvant therapy in order to 
shrink the tumor, making the operation pos-
sible. Neoadjuvant therapy has been found 
to be as eff ective as postoperative therapy in 
terms of survival, disease progression and dis-
tant recurrence (Mauri ). Adjuvant sys-
temic treatment given aft er surgery as diff erent 
combinations of cytotoxic drugs has proven 
eff ective in reducing recurrence and death 
rates, and the eff ect can last more than  years 
aft er the treatment (Hortobagyi , Early 
Breast Cancer Trialists’ Collaborative Group 
). It is given to patients with a high risk of 
recurrence and also to women with metastatic 
breast cancer when curative surgery is not pos-
sible. Hormone therapy has been observed to 
be eff ective in reducing recurrence and death 
rates in both premenopausal and postmeno-
pausal women with hormone receptor-positive 
tumors (Early Breast Cancer Trialists’ Col-
laborative Group , ). Th e most com-
monly used antiestrogen drug is tamoxifen. 
Recently, aromatase inhibitors have been ap-
proved for use in postmenopausal women as 
the initial hormone therapy or aft er tamoxifen 
(Winer ). Th e monoclonal antibody tras-
tuzumab, which targets the HER/neu protein 
of breast tumors, has been eff ective in increas-
ing survival in women with metastatic breast 
cancer (Cobleigh , Slamon , Vogel 
). Data also show that women taking tras-
tuzumab in addition to chemotherapy have a 
reduced recurrence of cancer compared with 
women receiving chemotherapy alone (Hamp-
ton , Romond ).
2.1.4. Prognosis
Th e majority of patients are cured perma-
nently. Nowadays, about    of patients are 
alive  years aft er the diagnosis,    aft er  
years,    aft er  years, and    aft er  
years (Ries ). Th e prognosis was worse 
in ; in USA,    of the patients whose 
cancer was diagnosed fi ve years earlier were 
alive, and only    ten years aft er the diag-
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nosis. (National Cancer Institute b). Th e 
fi ve-year relative survival rate is slightly lower 
in the youngest age groups;    of patients 
younger than  years are alive fi ve years aft er 
the diagnosis, compared with    of patients 
aged – years or    of those older than 
 years (American Cancer Society ). Th e 
most important factor aff ecting survival is the 
stage of the disease. Th e risk for recurrence in 
an early stage (I) is –   during ten years 
aft er the diagnosis and –   in stage II dur-
ing fi ve years aft er the diagnosis. Eighty-fi ve 
percent of the recurrences occur within the 
fi rst fi ve years, but recurrence can occur even 
– years aft er the diagnosis. 
Although the incidence of breast cancer 
continues to increase, mortality has been de-
creasing, principally as a result of earlier diag-
nosis and improvements in adjuvant systemic 
therapy. Th is means that increasingly more 
women with breast cancer treated years ago are 




Th e indications for breast reconstruction are 
loss of the breast because of surgery or absence 
or deformity of the breast for congenital or 
acquired reasons. Th is thesis deals with breast 
reconstruction aft er mastectomy for breast 
cancer. 
Patients who have had or are expected to 
have considerable asymmetry of the breast 
aft er tumor ablative surgery are suitable can-
didates for breast reconstruction. Most breast 
reconstructions are performed on patients 
undergoing a mastectomy. It is recommended 
that these patients should be counselled about 
reconstructive options before their tumor sur-
gery (Blamey ). Women with locally ad-
vanced disease may also be suitable candidates 
for breast reconstruction (Newman ). In 
the preoperative evaluation, aspects taken into 
account are disease status, future treatment 
plans, surgical history, and other health prob-
lems, volume of the contralateral breast, body 
habitus, the patient´s expectations (Piasecki 
), and the availability and skills of the sur-
gical team. 
Breast reconstruction is considered only 
if this is the patient’s wish. Aft er mastectomy, 
many women fi nd the external prosthesis very 
uncomfortable, and also experience physical 
and psychological disturbances in their body 
image. Th e wish for breast reconstruction is 
strongly related to age and working status. 
An estimated    of mastectomized patients 
younger than  years wish to have reconstruc-
tive surgery, while the corresponding fi gure for 
women over  years is only    (Korvenoja 
). 
Today, about   invasive breast can-
cers are diagnosed yearly in USA, and approxi-
mately    of these patients will have breast 
reconstruction (Jemal ). In Finland, of the 
 women diagnosed annually with breast 
cancer, mastectomy is performed on about 
–  , i. e. on – women. Breast 
reconstruction is performed on about    of 
women younger than  years. Th us, annually, 
some – patients undergo reconstuctive 
surgery aft er breast cancer in Finland (Stakes 
).
Relative contraindications for the proce-
dure are metastatic disease or severe medical 
comorbidities, e.g. massive obesity or marked 
cardiopulmonary problems.
2.2.2. Principles of breast reconstruction
In mastectomy, varying amounts of skin, breast 
tissue, and oft en the nipple-areola complex 
are removed. In traditional mastectomy, the 
amount of skin excised is quite large, while skin 
sparing mastectomy leaves most of the breast 
skin intact. Th e aim of breast reconstruction is 
to produce an optimal esthetic result by restor-
ing the volume, shape, soft ness, contour, and 
skin of the breast, using the opposite breast as a 
reference point. If the other breast is excessive-
ly large, its reduction may be needed. In such 
cases, the reductioplasty of the opposite breast 
and the breast reconstruction are performed 
during the same procedure, with the aim of 
producing breasts as symmetric as possible. 
Breast reconstruction can be performed at 
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the time of mastectomy (immediate breast re-
construction, IBR) or at a later stage, months 
or years aft er mastectomy (delayed breast re-
construction, DBR) (Cunningham , Feller 
, Hang-Fu ). Th e timing of the recon-
struction is considered by a multidisciplinary 
team consisting of surgeons and oncologists, 
and it depends on the patient’s preferences, the 
stage of the disease and the need for adjuvant 
therapy (Curtin ).
 Breast reconstruction has traditionally been 
carried out as a delayed procedure, but nowa-
days IBR has become the method of choice in 
many hospitals. IBR is ideal for patients with 
an early disease, stages I or II. It is considered 
oncologically safe in most cases, and has not 
caused a delay in chemotherapy or radiothera-
py according to the literature (Mustonen , 
Gouy ). In Helsinki University Central 
Hospital, IBR is recommended for patients 
requiring mastectomy for diff use DCIS, for 
patients with inherited susceptibility for breast 
cancer, for local recurrence aft er conservative 
surgery, or when mastectomy is needed be-
cause of multifocality or large size of the can-
cer (Jahkola ). DBR is considered a safer 
alternative if the patient is expected to receive 
oncological treatment for an invasive cancer. 
IBR could cause a delay in the start of chemo- 
or radiotherapy when there are problems in 
wound healing (Jahkola , Pomahac ). 
Compared with DBR, the esthetic result of IBR 
is oft en better because the skin envelope and 
the inframammary fold are maintained (Kroll 
), and also the cost of the treatment is re-
duced because of one operation instead of two 
(Khoo ). Aft er successful IBR, it may be 
easier for the patient to manage with the psy-
chological stress caused by loss of the breast 
(Rosenqvist , Al-Ghazal ). Th e breast 
mass can be restored and the breast contour 
recreated with nonautologous breast recon-
struction by inserting an artifi cial implant, with 
autologous breast reconstruction using the pa-
tient’s own tissue to reform the breast, or with 
a combination of these methods. Selecting the 
type of reconstruction depends on the patient’s 
comorbidities, previous surgical history, body 
habitus, and the possibility of pregnancies in 
the future. Autologous breast reconstruction 
is recommended for patients generally healthy 
except for the breast cancer (Tachi ). If the 
patient is a heavy smoker or has severe comor-
bidities aff ecting the microcirculation, such as 
diabetes, cardiovascular diseases, or coagula-
tion tendency, a nonautologous reconstruction 
or no reconstruction is oft en recommended. 
Some characteristics of diff erent types of 
breast reconstructions are shown in Table II.
2.2.3. Nonautologous breast reconstruction
Th e simplest breast reconstruction technique is 
to place a breast implant subcutaneously or un-
der the pectoralis major muscle. Th e implant is 
a bag fi lled with silicone or saline, and it can be 
of fi xed or adjustable volume. If the breast tu-
mor has been operated on using a skin sparing 
technique, a prosthesis of fi xed volume can be 
used. Th ere are various types of implants with 
diff erent forms and surfaces. Fixed volume im-
plants are suitable for selected patients, when 
the desired volume of the reconstructed breast 
is small. Th ey are also used to give additional 
volume in connection with an autologous 
Table II. Some characteristics of the main types of breast reconstructions.






(pedicled TRAM fl ap)
Autologous 
(free TRAM fl ap)
Duration of operation 1–2 hours 3–4 hours 3–6 hours 4–6 hours
Need of surgical teams





no no sometimes yes
Length of hospital stay 2–3 days 3–4 days 5–7 days 5–7 days
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reconstruction, e.g. the latissimus dorsi fl ap 
(Ahmed ). Th e lengths of operation and 
hospital stay are shorter in nonautologous than 
autologous reconstructions. Earlier, a high in-
cidence of fl ap necroses, wound dehiscence, 
implant extrusions, and peri-implant contrac-
tures has been reported aft er subcutaneous ap-
plication of a silicone breast implant because of 
insuffi  cient overlying skin to cover the subcu-
taneously placed prosthesis aft er mastectomy 
(Watts , Vandamme ). 
Nowadays a nonautologous breast recon-
struction is performed in many centers in two 
phases with an expander prosthesis (Agha-
Mohammadi ). First, a tissue expander 
is placed under the pectoralis muscle. Th is is 
an empty silicone bag, which is gradually over 
a few weeks infl ated with saline, in an outpa-
tient setting, to stretch the overlying tissue. 
Some months later, in a second operation, the 
expander is removed and replaced with an 
implant. Th e second operation can be avoided 
by using a Becker-type expandable prosthesis, 
which has a remote injection port. When the 
expander is fully infl ated, the injection port 
is removed and the prosthesis left  in place 
(Becker ). Th e expander technique for 
breast reconstruction is suitable for women 
with a relative lack of skin aft er mastectomy 
and small nonptotic breasts (Ahmed ). It 
is a good method also for young women with 
bilateral prophylatic mastectomies, for whom 
a bilateral TRAM fl ap reconstruction is not 
a good option because of future pregnancies 
(Jahkola ).
Th e most common complication associated 
with breast implants is capsule contracture, 
resulting in a fi rm and spherical breast, breast 
asymmetry, and possible implant displacement 
(Tachi ). Th e capsulated prosthesis must 
sometimes be removed and a new reconstruc-
tion made, causing increasing costs and incon-
venience for the patient. Capsular contracture 
commonly develops aft er post-reconstruction 
radiotherapy (Spear ). Th e safety of sili-
cone in breast implants has been discussed 
widely. Some leakage is thought to occur in 
most implants because of degradation of the 
outer layer (Tachi ). Th e association be-
tween silicone implants and increased risk of 
connective tissue diseases has thus far not been 
confi rmed (Janowsky ).
2.2.4. Autologous breast reconstruction
Th e problems arising from breast reconstruc-
tions with an implant provided the motivation 
to develop new methods for breast reconstruc-
tion without any foreign material. Th e fi rst 
report of an autologous breast reconstruction 
was published in  (De Cholnoky ). 
Breast reconstruction with the patient’s own, 
autologous tissue is considered the optimal 
method for creating a natural-looking and 
-feeling breast. Autologous breast reconstruc-
tion consists of taking a fl ap of tissue from a 
donor site and transferring it to the site of 
the removed breast. Th e autologous fl aps 
for breast reconstruction are oft en obtained 
from the lower abdomen or the upper back 
and sometimes the gluteal region. Tradition-
ally, the fl ap has consisted of muscle and the 
overlying fascia, subcutis, and skin accompa-
nied by the vessels nourishing these tissues. 
Factors aff ecting the selection of the tissue for 
reconstruction include the amount of tissue 
needed and the amount of tissue available at 
the donor site. Th e wishes and lifestyle of the 
patient are also considered when choosing 
the fl ap (Jahkola ). Although the surgical 
procedure is complex and time-consuming, 
the result of a ptotic, soft , symmetrical recon-
structed breast is usually better than the result 
achieved with nonautologous reconstruction. 
Moreover, the implant-related complications 
are usually avoided. Autologous fl aps for breast 
reconstruction tolerate postoperative radiation 
therapy well (Zimmermann , Pomahac 
). 
Th e fl ap can be transferred as a pedicled or 
free fl ap or a combination of these two meth-
ods. A pedicled fl ap is dissected from its sur-
roundings and turned to the recipient site so 
that it remains attached to its original blood 
vessels. Th e use of the pedicled latissimus 
dorsi (LD) musculocutaneous fl ap from the 
patient´s upper back was described for breast 
reconstruction by Scneider with coworkers in 
 (Schneider ). It is a reliable fl ap with 
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a good blood supply. It is a popular method for 
breast reconstruction for women with fairly 
small breasts. Th e additional scars on the back 
and the usually required breast implant or ex-
pander, with the possibility of capsular contrac-
ture, may limit its use (Tachi ). In , 
Robbins published the original description of 
the successful use of a vertical superiorly based 
rectus abdominis musculocutaneous fl ap for 
breast reconstruction in four women (Rob-
bins ). Hartrampf and colleagues pub-
lished in  anatomical and clinical studies 
of the lower abdominal pedicled TRAM fl ap 
for breast reconstruction (Hartrampf ). 
Th e lower TRAM fl ap with its variations is 
the current gold standard of autologous breast 
reconstruction (Grotting , Piasecki , 
Serletti ). Th e pedicled and free TRAM 
fl aps with their subtypes are described in de-
tail later in the text. Th e TRAM fl ap has many 
advantages compared with other methods for 
autologous breast reconstruction. Th e new soft  
and natural-looking breast can be created in 
one surgical procedure, it is easier to produce 
symmetry with the other breast, the patients 
are usually happy to get rid of unwanted excess 
abdominal fat tissue, and the scars of the opera-
tion are well concealed (Grotting , Serletti 
). Th e result of TRAM fl ap reconstruction 
is shown in Figure .
Usually, only one of the rectus muscles is 
used for unilateral breast reconstruction to 
limit any postoperative problems to the ab-
dominal wall. Choosing which one of the rectus 
muscles is used depends on the type of TRAM 
fl ap reconstruction, the amount of tissue need-
ed, and the shape of the other breast (Schefl an 
b, Hartrampf , Chang b, Serletti 
). When the TRAM fl ap is unavailable be-
cause of extensive scars aft er lower abdominal 
operations or the patient is exceptionally thin 
or very obese (Tachi , Jahkola ), the 
pedicled fl aps used are usually the LD fl ap, the 
thoracodorsal artery-perforator fl ap (TAP) 
(Angrigiani ), or the lateral thoracodorsal 
fl ap (Holmström ). 
When transferring a free fl ap, the fl ap is 
elevated from its original position, its pedicle 
vessels are dissected, their proximal ends are 
ligated, and then the pedicle vessels are cut. 
Th e fl ap is then lift ed to its fi nal destination, 
which has been prepared for the transfer, and 
the pedicle vessels are anastomosed to the re-
cipient blood vessels near the mastectomy area 
with a microsurgical technique. Th e use of a 
free TRAM fl ap for breast reconstruction was 
fi rst reported by Holmström in  (Holm-
ström ) and later popularised by Grotting 
(Grotting ). To avoid problems caused by 
harvesting part of the rectus abdominis mus-
cle, newer modifi cations of the free TRAM fl ap 
have been created, including the deep inferior 
epigastric perforator fl ap (DIEP) (Koshima 
, Allen ) and the superfi cial infe-
rior epigastric artery (SIEA) fl ap (Arnez ). 
Th ese fl aps consist of skin and subcutaneous 
tissue with the nourishing vessels, leaving the 
rectus muscle in place. When these modifi ca-
tions of the free TRAM fl ap are unavailable or 
unusable, the superior or inferior gluteal free 
fl aps (Shaw , Paletta ), the gluteal 
perforator free fl ap (GAP) (Blondeel ), the 
lateral transverse free thigh fl ap (Elliott ), 
the free laparoscopically harvested omental 
fl ap (Cothier-Savey , Jiminez ), and 
the Rubens fl ap (Hartrampf , Elliott ), 
among others may be suitable. 
In Finland most of the breast reconstruc-
tions are performed with the LD fl ap with or 
without an implant, or with the TRAM fl ap and 
its modifi cations. Th e diff erent types of breast 
reconstruction performed at the Department 
of Plastic Surgery, Helsinki University Central 
Hospital, in  are presented in Table III. 
Figure 1. Result of breast reconstruction with a TRAM 




2.2.5. The TRAM fl ap
Pedicled TRAM fl ap
Th e technique for breast reconstruction with a 
pedicled TRAM fl ap has not changed essential-
ly from the procedure described by Hartrampf 
and colleagues in  (Hartrampf , Har-
trampf , Grotting , Serletti ). Th e 
pedicled TRAM fl ap is a good option for breast 
reconstruction in patients who are generally 
healthy nonsmokers, of normal weight or only 
moderately obese, and have suitable tissue in 
the lower abdomen (Serletti ). 
Th e fl ap is formed of a transverse elliptiform 
skin island raised from the lower abdominal 
area, mostly below the umbilicus, with the un-
derlying subcutaneous fat and the rectus abdo-
minis muscle (whole or its medial two-thirds) 
with its vessel pedicle. Usually the muscle op-
posite to the mastectomy side is chosen. Th e 
operation is performed under general anes-
thesia. Stable hemodynamics and mild hyper-
volemic hemodilution are maintained during 
the operation and postoperatively, and a de-
crease of temperature is prevented, as recom-
mended for microvascular operations (Robins 
, Macdonald , Sigurdsson ). Th e 
operation is usually performed by two micro-
surgically experienced teams. Th e principles 
of this operation are outlined in Figure . Th e 
preselected skin island, about  cm in width 
and – cm in height, is dissected from its 
surroundings. Th e distal half of the skin-sub-
cutis island, contralateral to the muscle side, is 
fi rst elevated from the abdominal wall fascia as 
far as to the linea alba. Th e ipsilateral half of 
the skin fl ap, lying over the rectus muscle, is 
then dissected, leaving three medial centime-
ters of the anterior rectus sheath on the fl ap. 
Th e two rows of musculocutaneous perforators 
run through this strip of the rectus sheath. Th e 
rectus abdominis muscle is then cut above the 
arcuate line. At this stage, the fl ap has a double 
circulation through the inferior and superior 
epigastric vessels. Th e inferior epigastric ves-
sels are then cut, and the fl ap, which is now 
perfused by the superior epigastric vessels, is 
tunnelled under the upper abdominal skin and 
subcutis to the mastectomy area. Th e breast 
is shaped by rotating the fl ap ° so that the 
medial side of the reconstructed breast repre-
sents the contralateral side of the fl ap. Th e dis-
tal portion of the contralateral side skin (zone 
IV, see Section ...) is discarded. During the 
operations presented in this thesis, the ab-
dominal wall was reconstructed without mesh 
using nonabsorbable continuous sutures to the 
fascia. Nowadays, the defect in the abdominal 
fascia is usually repaired with synthetic mesh 
(Serletti ).
Free TRAM fl ap
Th e use of a free TRAM fl ap for breast recon-
struction was fi rst reported by Holmström in 
 (Holmström ). Aft er the studies of 
Grotting and coworkers (Grotting ) sug-
gesting better blood fl ow in the free than the 
pedicled TRAM fl ap, the free fl ap has gradually 
exceeded the pedicled fl ap in popularity (Tachi 
, Serletti ). Th e free TRAM fl ap is 
thought to be more reliable than the pedicled 
TRAM fl ap in smokers, in patients with pre-
vious abdominal scars, and in patients with 
marked obesity, diabetes, hypertension, or 
other diseases aff ecting the microcirculation 
(Tachi , Serletti ). 
Th e principles of this operation are shown 
in Figure . Th e skin-subcutis island of the 
free TRAM fl ap is raised in the same way as 
with the pedicled TRAM fl ap. A small area 
(length about , cm, width ,– cm) ) of the 
anterior rectus fascia containing the medial 
Table III. The different methods used for breast reconstructions performed after mastectomy for patients 
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and lateral perforators overlying the fascia is 
incised. Under the fascia, a -cm portion of 
the rectus abdominis muscle extending from 
the level below the umbilicus to the arcuate 
line is prepared to be taken within the fl ap. A 
lateral narrow strip of the innervated rectus 
muscle is left  in place to avoid contraction of 
the muscle edges. Today, a medial strip of the 
muscle is also left  in place; this is believed to 
help maintain the abdominal muscle tonus. At 
this stage, the recipient vessels in the mastecto-
my area are prepared. At the time of the studies 
in this thesis, the thoracodorsal or the scapular 
circumfl ex vessels were used as recipient ves-
sels in our hospital. Later on it has been stated 
that if an axillary node dissection has been or is 
being performed the thoracodorsal vessels are 
to be used as the recipient vessles of the fl ap. 
For patients with total mastectomy without 
axillary node dissection or with sentinel node 
biopsy only, the internal mammary vessels are 
preferred (Dupin , Serletti ). When 
the appropriate vessels have been dissected in 
the thoracic area, the inferior epigastric vessels 
are dissected down to their origin from the 
external iliac vessels, part of the rectus muscle 
is cut at both ends, and the superior epigas-
tric vessels are ligated and cut. Th e inferior 
epigastric vessel pedicle is then divided and 
clamped, and the fl ap lift ed to the chest. Th e 
pedicle vessels are anastomosed end-to-end 
with a microsurgical technique to the recipient 
vessels, usually the vein fi rst. Aft er completing 
the anastomoses, the abdominal wall is closed 
by nonabsorbable sutures, nowadays with the 
help of inlay mesh when needed. Th e neobreast 
is designed, situating the former umbilical 
area caudally and the contralateral side of the 
fl ap medially. Excessive or nonviable skin and 
subcutis of the fl ap, especially in zone IV, is re-
moved at the closing phase. 
Other variants of the TRAM fl ap 
Many modifi cations and refi nements have been 
made to the TRAM fl ap to ensure suffi  cient 
blood fl ow to the reconstructed breast and to 
diminish donor-site morbidity. Th e bipedicled 
TRAM fl ap is based on the traditional skin-
subcutis island and both of the rectus muscles 
with their superior epigastric pedicles. It is 
expected that blood fl ow provided by both of 
the superior pedicles is better than blood fl ow 
through a traditional pedicled TRAM fl ap. Th e 
bipedicled fl ap is used when additional fl ap tis-
sue is needed for creating a large neobreast for 
a woman with a limited amount of abdominal 
tissue, and for patients with lower abdominal 
midline scarring. One of the major disadvan-
tages of a bipedicled fl ap is the increase in do-
nor-site morbidity (Ishii , Wagner , 
Simon ).
One way to try to enhance the TRAM fl ap 
blood fl ow is to create an augmented or “su-
percharged” TRAM fl ap. In this procedure the 
inferior epigastric, superfi cial epigastric, or 
superfi cial circumfl ex iliac vessels of the ipsi-
Figure 2. Principles of breast reconstruction.  The preoperative situation is presented in Fig. 2 A, the pedicled 
TRAM fl ap in Fig. 2 B and the free TRAM fl ap in Fig. 2 C. The superior epigastric artery (SEA) and the deep 
inferior epigastric artery (DIEA) are marked in the pictures.
A B C
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lateral or contralateral side of a conventional 
pedicled TRAM fl ap are anastomosed to re-
cipient vessels in the axilla (Harashina , 
Schefl an ). A “recharged” TRAM fl ap has 
also been developed, where the ipsilateral 
(muscle side) deep inferior epigastric vessels 
of a pedicled TRAM fl ap are anastomosed to 
the deep inferior vessels of the contralateral 
side (skin-subcutis island) of the fl ap (Berrino 
). Attempts to improve venous outfl low 
from the pedicled TRAM fl ap have been made 
by anastomosing veins of the ipsilateral or 
contralateral side to veins in the axillary area 
(Barnett , Yanaga ). 
To decrease the disadvantages caused by 
harvesting the rectus muscle, minimal amounts 
of the rectus muscle can be included in a free 
TRAM fl ap, thus being called the muscle-spar-
ing free TRAM fl ap. Aft er the s, perforator 
fl aps have become popular in reconstructive 
surgery. Th e DIEP fl ap is a free fl ap formed of 
the same skin-subcutis island as the TRAM 
fl ap. It is based on the perforator vessels origi-
nating from the inferior epigastric vasculature 
(Koshima , Allen ). Only a small 
amount of the muscle and anterior rectus fas-
cia around the perforator is enclosed within 
the fl ap. Th e fl ap is attached to the mastectomy 
site in the same way as the free TRAM fl ap. Th e 
frequency of using DIEP fl aps is on the rise, as 
surgeons become more comfortable with the 
meticulous operation technique.
Th e SIEA fl ap is also used as a free fl ap for 
breast reconstruction (Grotting , Arnez 
). It consists of a skin-subcutis island from 
the lower abdomen, based on the superfi cial 
inferior epigastric vessel pedicle. Th e muscle 
and fascia remain completely intact during the 
procedure, which is the main advantage of this 
method. Th e superfi cial inferior epigastric ar-
tery arises from the femoral artery, about  cm 
below the inguinal ligament, and turns upward 
in front of the inguinal ligament. Th e SIEA fl ap 
can be used only if an adequate SIEA is pres-
ent. It is not found in about half of the patients, 
and in many patients the vessel caliber is too 
small (Chevray ). 
2.2.6. Surgical complications of 
the TRAM fl ap
Surgical complications and total fl ap loss
Postoperative infections and hematomas are 
rare in breast reconstructions with the TRAM 
fl ap (Serletti ). Th e most common surgi-
cal complications are problems related to the 
abdominal donor site, the overlying mastec-
tomy skin, or the fl ap itself. Early abdominal 
wall complications include seroma formation 
and delayed healing of the abdominal incision, 
sometimes leading to necrosis of the umbilicus 
or the abdominal skin. Th e most common late 
abdominal wall complications are laxity, hernia, 
and chronic pain (Blondeel , Reece , 
Nahabedian a). To decrease abdominal 
wall complications, medial and lateral portions 
of the rectus muscle can be left  in place during 
pedicled and free TRAM fl ap elevations and a 
synthetic mesh can be used for closure of the 
abdominal wound. 
Aft er undermining, the mastectomy skin 
area sometimes heals slowly and part of the 
skin may be lost. Th is is considered to be due 
to inadequate resection of compromised skin 
during mastectomy. Th e slow healing can de-
lay the onset of chemotherapy aft er immediate 
breast reconstruction in some cases (Serletti 
).
Th e most important and serious complica-
tions related to the TRAM fl ap are total or par-
tial loss of the fl ap. Total fl ap loss is the result 
of irreversible cessation of blood fl ow in the 
fl ap, usually leading to failure of the breast re-
construction. Flap ischemia can occur because 
of arterial thrombosis, venous thrombosis, or 
the fl ap being too large for its intrinsic blood 
supply (Kerrigan ). Typical rates of post-
operative thrombosis lie between    and    
(Serletti ). In pedicled fl aps, thrombosis is 
usually due to a microcirculatory low-fl ow state 
caused by improper fl ap design, ischemia-rep-
erfusion injury, systemic factors (hypotension, 
sepsis, vasoconstrictors or smoking), or local 
compression of the pedicle or the fl ap (Vedder 
). Suffi  cient reduction of venous blood 
fl ow can produce fl ap necrosis in spite of ad-
equate arterial fl ow (Fujino ). In free fl aps, 
the fl ap failure is usually caused by thrombosis 
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of the pedicle artery or vein at the site of the 
microvascular anastomosis. Venous occlusion 
is more common than arterial occlusion in free 
fl aps, leading to total fl ap loss if not treated in 
time (Vedder ). Venous or arterial occlu-
sion is speculated to be a consequence of poor 
surgical technique, leaving adventitia or media 
of the vessel exposed to blood-carrying fi brin 
and platelets (Vedder ). Kinking or exter-
nal compression of the artery or vein can also 
be the stimulus leading to occlusion of the ves-
sel. Patients with a hypercoagulative tendency 
may be at risk for fl ap failure. It might be useful 
to preoperatively measure blood levels of some 
markers for coagulation and fi brinolysis (Ols-
son ). Flap salvage is oft en successful with 
immediate return to the operating room. Th e 
incidence of total fl ap loss is usually less than 
   in pedicled fl aps and between    and    
in free fl aps (Table IV). 
Th e learning curve of a complex procedure 
aff ects the rate of complications. In a retrospec-
tive series of  breast reconstructions with 
free TRAM fl aps during -, the overall 
complication rate was    among the fi rst  
patients, but decreased to –   in the rest 
of the patients, probably because of the team 
getting experience on the procedure routines 
(Nieminen ).
Cutaneous and fat necrosis 
in the TRAM fl ap
Partial fl ap loss is observed as cutaneous or fat 
necrosis. It is the result of locally inadequate 
blood fl ow, which can be caused by, for in-
stance, vasoconstriction of the small arterioles 
or too low perfusion pressure in the distal 
cutaneous and subcutaneous areas of the fl ap 
(Vedder ). 
Cutaneous necrosis of the fl ap develops 
early, within a few days to weeks aft er the op-
eration. It is seen clinically as dark edges of the 
TRAM fl ap, with no signs of local blood fl ow. It 
is usually treated with dressing changes and in 
some cases with surgical revision. Cutaneous 
necrosis oft en lengthens the hospital stay and 
costs, and exposes the patient to additional op-
erations. A TRAM fl ap with cutaneous necro-
sis is shown in Figure . Fat necrosis is a form 
of partial fl ap loss. It results in a fi rm mass 
Table IV. Incidence of total or partial fl ap loss in pedicled and free TRAM fl aps.
Study TRAM fl ap type Number of fl aps Total fl ap loss (%) Partial fl ap loss (%) Fat necrosis (%)
Hartrampf 1987 Pedicled 432 0.5 5.2 5.2 
Schusterman 1992 Pedicled 48 0 17 23
Elliott 1993 Pedicled 128 0 10 N/A
Kroll 1998 Pedicled 67 N/A N/A 26.9
Paige 1998 Pedicled 127 N/A 10 12.6
Clugston 2000 Pedicled 252 0 2 7.1
Garvey 2006 Pedicled 94 8.5 58.5† †
Schusterman 1994 Free 211 1 7† †
Trabulsy 1994 Free 99 4 6 N/A
Kroll 1998 Free 49 N/A N/A 8.2
Nieminen 1999 Free 185 1 4,3 N/A
Chang 2000b Free 936 5.1 $ 6.2 N/A
Kroll 2000 Free 279 0 2.2 12.9 
Nahabedian 2002b Free 143 3.5 0 9.8
Scheer 2006 Free 46 4.3 6.5 9.0
N/A not reported. $ 38,5 % of patients moderately or massively overweight. † includes partial cutaneous, and fat necrosis.
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in the subcutaneous tissue. It develops later 
than cutaneous necrosis, generally one to six 
months postoperatively. Th e diagnosis is made 
clinically or with ultrasound or mammography. 
Th e fat necrosis area can be observed without 
surgical interventions, or resected, as needed 
(Kroll ). Partial fl ap loss is seen in –   
of pedicled TRAM fl aps and in –   of free 
TRAM fl aps (Table IV).
Factors aff ecting the risk of partial fl ap loss 
in TRAM fl aps include smoking and obesity. 
Cutaneous necrosis is seen more commonly in 
smokers than in non-smokers (Chang a, 
Padubidri , Selber , Booi ). In 
addition, some studies suggest that smoking 
increases the incidence of fat necrosis (Kroll 
, Selber ), while others report no ef-
fect. (Alderman , Nahabedian b). Th e 
role of overweight in development of cutaneous 
and fat necrosis of TRAM fl aps is described in 
Section ... 
2.3. Blood fl ow in surgical fl aps
2.3.1. Blood fl ow of the skin
Th e fi rst accurate publication of blood fl ow 
to the skin was submitted by Harvey in  
(Harvey ). Tomsa subsequently described 
the subdermal and dermal plexuses of the skin 
in  (Tomsa ), and Spateholz the direct 
and indirect perforators to the skin (Spateholz 
). In , Manchot described in detail 
the cutaneous blood supply and identifi ed dis-
tinct skin territories, each receiving its blood 
fl ow from its own source vessel (Manchot 
). His work formed the basis of the studies 
of Salmon, who found that in reconstructive 
surgery a fl ap must include an arterial pedicle 
(Salmon a, b). Knowledge of blood 
fl ow of skin has since remained relatively un-
changed.
Nowadays, the vasculature of the skin and 
subcutis is believed to consist of fi ve vascular 
plexuses (Figure ). Th e most superfi cial is 
the subepidermal plexus, beneath which run 
the dermal, subdermal, subcutaneous, and the 
fascial plexuses. Each plexus is a horizontal 
fi ne meshwork of interconnecting vessels. Th e 
plexuses have a huge capacity for distributing 
blood fl ow to the skin and subcutis. Th e der-
mal plexus with its muscular arteriolar vessels 
is the main thermoregulatory system, and the 
subdermal plexus with its thin-walled capil-
laries is the main site for nutrient exchange 
(Blondeel ). 
Th e blood fl ow to the vascular plexuses of 
the skin and subcutis is supplied through the 
perforator arteries, which arise from source 
arteries below the deep fascia (Blondeel ). 
Th ey are described in Section ...
2.3.2. Regulation of cutaneous blood fl ow
Normal blood fl ow to the skin is about  ml 
per  g of tissue at rest. Th e blood fl ow to 
Figure 3. The right breast of a patient who underwent breast reconstruction with a pedicled TRAM fl ap. Cutaneous 
necrosis on the fi rst (A) and seventh (B) postoperative day. The necrosis is seen at the edge of the contralateral 
skin of the fl ap (zone IV), now situated on the medial side of the new breast. Surgical revision was required.
A B
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tissues of the body is controlled by the needs 
of the tissue itself (Guyton ). Several fac-
tors regulate the vascular tone of skin vessels, 
including the autonomic nervous system, 
cerebral functions such as emotions, ocular 
stimuli, and sounds, and other factors such as 
orthostatic position, nutrients, medicines, and 
smoking. Peripheral vessels are in constant va-
somotion, refl ected as rhythmic contractions 
six to eight times per a minute (Vedder ). 
Cutaneous blood fl ow is regulated at the lo-
cal and systemic level and by the baroreceptor 
mechanism. In the local control of cutaneous 
blood fl ow, the microvessels of the skin contin-
uously monitor the levels of oxygen, nutrients 
and carbon dioxide. Th ey regulate the circula-
tion by constricting or dilating local blood ves-
sels within seconds to minutes to provide the 
ideal level of tissue blood fl ow needed for each 
type of activity. Hypercapnia, hypoxia, and 
acidosis cause vasodilation. Increased tissue 
perfusion can induce a myogenic refl ex seen 
as vasoconstriction and decreased blood fl ow. 
Blood fl ow of skin decreases also as a result of 
elevated viscosity of the blood and local hypo-
thermia (Guyton , Vedder ),
Systemic regulation can occur neurally and 
humorally. Th e sympathetic vasoconstrictor 
and vasodilator nerves modify the vessel tonus. 
Th e cutaneous arteriovenous anastomoses are 
richly innervated by the sympathetic vasocon-
strictor nerves (Lossius , Crandall ). 
A neural stimulus through the sympathetic fi -
bers to the α-adrenergic receptors of the vascu-
lar smooth muscle induces constriction of the 
precapillary sphincters and arterioles, and the 
blood fl ow is directed, instead of to the capil-
laries, through arteriovenous shunts to venules 
and veins. Accordingly, sympathetic stimula-
tion of the β-adrenergic receptors induces va-
sodilation. Th e sympathetic regulation through 
serotonergic receptors situated at arterio-
venous anastomoses induces vasoconstriction. 
Humoral regulation means regulation of blood 
fl ow by hormones, ions, and other substances 
of the body fl uids, stimulating the specifi c re-
ceptors in the tissue. Th ese substances can ap-
proach the tissue through the bloodstream or 
be secreted locally in the tissue. Norepineph-
rine, epinephrine, angiotensin, vasopressin, se-
rotonin, thromboxane A, and endothelin are 
the most important vasoconstrictors. Bradyki-
nin, prostacyclin, and histamine are examples 
of vasodilatory substances (Guyton , Ved-
der ). 
2.3.3. Principles of blood fl ow in fl aps 
In reconstructive surgery, even large tissue 
defects can be successfully repaired with fl aps. 
Planning and choosing of the most suitable 
fl ap for each purpose is based on knowledge of 
blood fl ow and behavior of the fl ap. Th e fl aps 
Figure 4. A schematic representation of the vascular structure of the skin and subcutis. From Mathes SJ and 
Nahai F: Reconstructive Surgery; Principles, Anatomy & Technique. Churchill Livingstone Inc. (Elsevier), New 
York, USA 1997, p 15. Printed with the kind permission of the publisher.
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can be classifi ed, based on their structure, as 
muscle or fascial fl aps. If skin is included in the 
fl ap, it is called analogously a musculocutane-
ous or fasciocutaneous fl ap. Other tissues with 
vascular connections to the muscle or fascia 
can also be included in the fl ap, e. g. bone, 
tendon, bowel, or omentum. Th e known fl aps 
have a fairly constant pattern of blood fl ow 
through a vascular pedicle consisting of an ar-
tery and vein. Th e pedicle or pedicles are called 
dominant if they can provide the blood fl ow 
of the whole fl ap area. Minor pedicles cannot 
guarantee the fl ap blood fl ow alone, without 
the dominant pedicle (Mathes , Blondeel 
).
Th e angiosome concept developed by Taylor 
and Palmer (Taylor ) lies at the founda-
tion of harvesting fl aps in modern reconstruc-
tive surgery. Th e angiosome was described as 
a three-dimensional composite unit of tissue 
supplied by a specifi c source artery. Th e com-
posite contains muscle, nerve, connective tis-
sue, bone, and overlying skin. Th e body is di-
vided in  angiosomes based on named source 
arteries, and some angiosomes are divided into 
smaller territories. Th e angiosomes are usu-
ally interconnected with adjacent angiosomes 
through reduced caliber choke anastomotic 
vessels or sometimes through ordinary anas-
tomoses without caliber reduction. Th e outer 
limit of each territory is defi ned by the position 
of choke vessels. Th e choke vessels can regulate 
the blood fl ow of the angiosome by dilating or 
constricting as needed. 
Th e venous drainage of the body mirrors 
the arterial supply in the deep tissues and in 
most areas of the skin and subcutis in the head, 
neck, and torso. Th e choke arteries are accom-
panied by oscillating veins (Taylor ). Each 
angiosome consists of matching arteriosomes 
and venosomes.
Th e elevation of a fl ap is followed by loss 
of sympathetic innervation and spontaneous 
release of vasoconstricting neurotransmit-
ters. Many nutrient vessels are also cut. Th ese 
mechanisms lead to an acute decrease in fl ap 
fl ow (Vedder ). 
In experimental studies, aft er denervation 
blood fl ow has been observed to increase in 
skeletal muscle (Chen , Chen , Siemi-
onow , Wang ) and in skin fl aps (Fin-
seth , McKee ) because of arteriolar 
vasodilation and increased capillary perfusion. 
Th e eff ect of sympathectomy on muscle blood 
fl ow has been investigated in rats. Proximal 
sympathectomy with somatic denervation 
caused a triphasic dynamic response in the 
peripheral microcirculation. During the fi rst 
few hours there is an initial hyperadrenergic 
phase seen as vasoconstriction. Aft er  hours, 
a nonadrenergic phase with vasodilation can 
be seen. Th is can last up to two weeks, aft er 
which a sensitized phase starts, with hyperre-
sponsiveness of the microvessels to vasoactive 
substances and a further increase in microcir-
culation (Banbury ). 
In animal studies, within a few hours af-
ter fl ap elevation blood fl ow in the tip of the 
fl ap decreases markedly, while blood fl ow in 
the proximal fl ap is preserved. Th e blood fl ow 
gradually increases to normal levels over the 
next month (Vedder ).
Neovascularization from the surroundings 
of the fl ap also increases the fl ap blood fl ow. 
Within minutes of closing a small blood vessel, 
the nearby collaterals are dilated as a neurogen-
ic or humoral phenomenon. During the next 
hours further opening of collaterals occur; the 
process continues for many months aft er the 
operation. Hypoxia is thought to stimulate for-
mation of local growth factors, such as VEGF, 
fi broblast growth factor, and angiogenin, which 
in turn stimulate new vessel growth from the 
small vasculature (Guyton ).
Clinical studies have found that the weight-
related intake of blood fl ow depends on the 
type of the free fl ap. Flaps with a large portion 
of fat, like the TRAM fl ap, have a low intake 
of blood compared with fl aps containing abun-
dant muscle (Lorenzetti a). In free fl aps, 
the fl ap blood fl ow is believed to be dependent 
on the hemodynamic requirements of the fl ap 
and not on the characteristics of the recipient 
artery (Lorenzetti b).
Pedicles of muscle and fascia
Th e blood fl ow of muscles is based on one or 
more vascular pedicles entering the muscle 
between its origin and insertion. Th e muscle 
pedicle consists of an artery and paired ac-
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companying veins, which are branches of the 
specifi c regional artery and vein. 
Th e vascular supply of muscles has been 
classifi ed to fi ve types according to the pattern 
of blood fl ow by Mathes and Nahai (Mathes 
). Th e principles of classifi cation of the 
vascular supply of muscles and fascia are 
shown in Figure .
According to the classifi cation of Mathes 
and Nahai:
• type I muscles are supplied by a single 
vascular pedicle (e. g. the tensor fascia lata 
muscle), 
• type II muscles have one dominant pedicle 
and one or more minor pedicles ( e. g. the 
gracilis muscle), 
• type III muscles have two large vascular 
pedicles arising from separate regional ves-
sels or the pedicles are located on opposite 
sides of the muscle (e. g. the rectus abdomi-
nis muscle), 
• type IV muscles have many segmental 
pedicles (for example the sartorius muscle) 
• and type V muscles receive their blood fl ow 
through one dominant vascular pedicle and 
several secondary pedicles (e. g. the latissi-
mus dorsi muscle). 
Th e blood fl ow of deep fascia is based on 
vascular pedicles entering the deep surface of 
the fascia and forming the vascular meshworks 
of the subcutis and skin (see Section ..). Th e 
vascular pedicles from deep fascia to the skin 
represent one of three types (Figure ): 
• Type A is a direct cutaneous pedicle. It 
originates from the regional vessels, runs 
closely beneath and superfi cially to the 
deep fascia and gives off  branches to many 
perforators to the skin. Th e SIEA fl ap used 
for breast reconstruction is based on a type 
A fasciocutaneous pedicle. 
• Type B is a septocutaneous (or intermus-
cular) pedicle running from major vessels 
between muscles up to the skin. In the ex-
tremities, most perforators are of the sep-
Figure 5. The principles of classifi cation of the vascular supply of muscles and fascia based on Mathes and 
Nahai (1981). From the article Tukiainen E, Suominen S: Kudoskielekkeet rekonstruktiivisen plastiikkakirurgian 
arkea. Duodecim 2007; 123: 987-997, with kind permission of Suomalainen Lääkäriseura Duodecim. The rectus 
abdominis muscle of the TRAM fl ap represents type III muscle and its pedicle represents a fasciocutaneous 
pedicle (type C).
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tocutaneous type. For example, the radial 
forearm fl ap has a type B pedicle. 
• Type C is a musculocutaneous pedicle. 
It runs from the regional vessels through 
muscle, and then travels as a perforator 
through the overlying deep fascia, fi nally 
participating in the subcutaneous and skin 
vascular networks. In the human body, 
musculocutaneous pedicles dominate on 
the trunk area, seen as perforators passing 
through fl at large muscles. Th e anterior 
thigh fl ap and the cutaneous part of the 
TRAM fl ap have musculocutaneous pedi-
cles (Mathes , Blondeel ). 
2.3.4 Blood fl ow in the TRAM fl ap
Th e conventional TRAM fl ap is an asymmetric 
fl ap consisting of part of one of the rectus ab-
dominis muscles, and a transverse elliptiform 
area of fascia, subcutis, and skin above the 
muscle.
Th e rectus abdominis muscle is a type III 
muscle with two main vascular pedicles (see 
Section ..). Th e two main pedicles are the 
superior epigastric vessels and the deep infe-
rior epigastric vessels. Th e superior epigastric 
artery (SEA) usually arises from the internal 
mammary artery and enters the rectus abdo-
minis muscle on its dorsal surface at the costal 
margin, then running in the inferior direction. 
In about    of patients, the SEA arises from 
the costomarginal artery (Milloy , Arnold 
, Miller ). Th e deep inferior epigas-
tric artery (DIEA) arises from the external iliac 
artery and enters the rectus muscle on its un-
dersurface below the arcuate line. Th e SEA and 
DIEA pedicles run inside the muscle as single-, 
double-, or triple-branched arteries to the pe-
riumbilical region (Boyd , Taylor , 
Moon , Watterson ), where the DIEA 
and SEA angiosomes communicate with each 
other through the choke vessels (see Section 
..).Anatomical and radiographic studies 
have shown that the DIEA is more signifi cant 
than the SEA in supplying the skin of the ante-
rior abdominal wall (Boyd ).
Th e so-called choke vessels are of macro-
scopic caliber in about    of people; in the 
rest, they are microscopic. In addition to the 
periumbilical choke vessels, the DIEA is con-
nected through choke vessels also inferiorly 
with the SIEA, inferolaterally with the superfi -
cial circumfl ex iliac artery, and superolaterally 
with the lateral cutaneous branches of the six 
lowest intercostal segmental arteries (Taylor 
, Miller ). Recently, communications 
between the costomarginal, musculophrenic, 
and intercostal arteries have been found 
(Marin-Gutzke ). Th e eff ect of the caliber 
of choke vessels on their function has not been 
studied.
Blood fl ow to the skin and subcutis of the 
lower abdominal and periumbilical areas is 
supplied through the musculocutaneous per-
forators. Th ese perforators run as branches 
from DIEA and SEA systems into and through 
the rectus muscle to the vascular plexuses of 
the overlying fascia and skin. Th e perforators 
run in two parallel rows through the anterior 
rectus sheath on both sides of the linea alba, 
the medial row – cm laterally to the linea 
alba, and the lateral row – cm medially 
from the lateral edge of the rectus muscle. Th e 
highest concentration of major perforators is 
in the paraumbilical area. Th eir caliber varies 
from very narrow to several millimeters (Boyd 
, Moon ). Th e perforators from DIEA 
and SEA have been investigated later. In two 
cadaver studies, the anatomy of DIEA perfo-
rators showed a homogenic pattern between 
individuals (Nakajima , El-Mrakby ), 
while in two cadaver and ex vivo fl ap studies 
the perforators of DIEA varied markedly in 
their orientation and size (Ohjimi , Tre-
gaskiss ). Th e perforators of SEA were 
found to have a more consistent course (Tre-
gaskiss ). Th e branching pattern of the 
DIEA has been examined recently with com-
puted tomography angiography. DIEA was ob-
served to be single, bifurcating, or trifurcating. 
Th e trifurcating type had the largest amount of 
perforators through the rectus muscle (Rozen 
).
In the pedicled TRAM fl ap, blood fl ow is 
supplied through the SEA, which is the non-
dominant pedicle of the anterior abdominal 
skin and subcutis (Boyd ). Th e free TRAM 
fl ap receives its blood supply through its domi-
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nant pedicle DIEA, which is anastomosed to 
the recipient artery in the thoracic area. 
In pedicled TRAM fl aps, blood fl ow to the 
ipsilateral skin and subcutis island, situated 
over the rectus muscle, comes through pa-
raumbilical and infraumbilical perforators, fi ll-
ing in a retrograde fashion from the superior 
epigastric system by means of the choke vessels. 
(Boyd ). Th e contralateral skin and sub-
cutis island receives its blood supply through 
anastomotic channels crossing the midline in 
the subdermal plexus (Taylor ) and by 
distinct subcutaneous arteries, mostly situated 
near the umbilical area (Kaufman ). Th e 
contralateral part of the skin-subcutis island is 
in fact a random-type fl ap. 
In free TRAM fl aps, blood fl ow to the ip-
silateral skin and subcutis comes mainly from 
the DIEA through the perforators. Th e contral-
ateral island of the free TRAM fl ap is supplied 
in the same way as in the pedicled fl ap.
Th e venous drainage of the TRAM fl ap skin 
is through paraumbilical perforator veins, in a 
similar way as the arterial fl ow, to the deep infe-
rior and the deep superior epigastric veins. Mid-
line crossover runs through several branches of 
the superfi cial and deep epigastric veins. In the 
deep inferior epigastric pedicle, two large ve-
nae commitantes drain to the iliac circulation. 
Th ese veins are larger than the ones following 
the SEA (Schefl an b, Watterson ). 
In addition, the superfi cial inferior epigastric 
veins add to the abundant venous outfl ow of 
the inferior veins. Th e deep inferior epigastric 
veins have valves that prevent retrograde fl ow 
(Costa , Taylor ). Th e periumbilical 
choke vessels have a bi-directional venous fl ow. 
When the pedicled TRAM fl ap is raised, distal 
venous outfl ow has to reverse from the inferior 
direction to the superior epigastric veins, pass-
ing the venous valves through the choke ves-
sels (Taylor , Moon ).
To understand the diff erent types of circula-
tion and to predict survival in diff erent parts 
of the TRAM fl ap skin, the skin of the fl ap 
island has been divided into four zones based 
on clinical experience and quality of perfusion 
(Hartrampf , Schefl an a and b). 
Th e zones are presented in Figure . Th e skin 
directly overlying the ipsilateral rectus muscle 
is considered zone I, and the same area on the 
contralateral side zone II. Th e skin lateral to 
the ipsilateral muscle is called zone III, and the 
skin lateral to the contralateral muscle zone 
IV. 
Th e zones were initially numbered in the 
order of assumed degree of perfusion. Cutane-
ous blood fl ow has been thought to be most 
reliable in zone I, and fairly reliable in the me-
dial parts of zone III as well as in the medial 
parts of zone II. Th e distal end of zone III and 
the lateral part of zone II are less reliable. Zone 
IV should be discarded routinely because it is 
prone to necrosis. When elevating a fl ap, the 
blood fl ow in an adjacent angiosome has been 
speculated to be quite reliable , becoming less 
reliable in more distant angiosomes, especially 
across the midline, as in zone IV in a TRAM 
fl ap (Taylor ). It has been suggested that 
zones II and III should be in reverse order 
because according to anatomical studies the 
ipsilateral perfusion is always better than the 
undirect perfusion to contralateral skin areas 
(Dinner , Moon ).
Hemodynamic studies on blood fl ow in 
TRAM fl aps have not been published before 
the studies presented in this thesis. Th e stud-
ies published thereaft er are presented in the 
Discussion.
Figure 6. The four zones of the TRAM fl ap based on 
cutaneous blood fl ow.
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2.3.5. Temperature and the cutaneous 
blood fl ow
Human body temperature is controlled cen-
trally by the thermoregulatory center in the 
preoptic/anterior hypothalamus in the brain. 
It receives information from the core and sur-
face temperatures and coordinates the eff erent 
responses regulating the temperature. During 
heat stress, an increase in core or surface tem-
perature leads to loss of heat via sweating and 
cutaneous vasodilation. During cold stress, 
reduced temperatures cause refl ex decreases in 
heat dissipation by cutaneous vasoconstriction 
and simultaneously heat production by shiver-
ing. During normothermia, skin blood fl ow 
averages about    of cardiac output. Th e cu-
taneous blood fl ow varies depending on body 
temperature; during maximal vasoconstric-
tion, as in cold stress, the absolute amount of 
blood in the skin is near to zero, and during 
maximal vasodilation in heat stress the cuta-
neous blood fl ow can consist of up to    of 
cardiac output (Rowell , Boulant , 
Kellogg ). 
Th e degree of thermoregulatory vasocon-
striction can be evaluated by the skin tempera-
ture gradient (Tgrad), which is determined as 
the diff erence between fi nger and arm temper-
atures (Stoen ). Tgrad correlates with fi n-
gertip blood fl ow in humans (Rubinstein , 
Akata ) and is thought to indicate the state 
of the arteriovenous shunts (Rubinstein ). 
Tgrad exceeding  °C is generally accepted to in-
dicate marked vasoconstriction, and Tgrad less 
than  °C is considered a sign of vasodilation 
(Stoen ). Th e concept thermoregulatory 
threshold is used for the level of core tempera-
ture at the stage when thermoregulatory vaso-
constriction begins (Stoen , Belani , 
Kasai , Pezawas ).
2.3.6. Effect of general anesthesia on ther-
moregulation and cutaneous blood fl ow
Unanesthetized subjects do not become hypo-
thermic in the ambient temperature of an op-
erating room because thermoregulatory vaso-
constriction with shivering usually maintains 
the core temperature near  °C (Stoen , 
Sessler ). During general anesthesia core 
temperature decreases in three phases (Ses-
sler , Hynson , Matsukawa a). 
During the fi rst hour the core temperature 
decreases at least  °C because of the core-to-
peripheral redistribution of body heat, caused 
by anesthesia-induced inhibition of tonic va-
soconstriction. Aft er this, the core temperature 
decreases slowly, in a linear fashion when heat 
loss exceeds metabolic heat production because 
of cooling. Finally, the core temperature stabi-
lizes when thermoregulatory vasoconstriction 
develops, reducing cutaneous heat loss and 
keeping metabolic heat in the core. General 
anesthesia reduces the thresholds for vaso-
constriction and shivering by approximately 
 °C (Sessler ) if the development of hy-
pothermia is not prevented. In reconstructive 
plastic surgery, the operations usually continue 
for many hours, and thermoregulatory vaso-
constriction, lasting for several hours postop-
eratively, frequently develops. Th e amount of 
uncovered skin during the operation also con-
tributes to development of hypothermia. Dur-
ing breast reconstruction with a TRAM fl ap 
large areas of the patient’s skin are exposed, 
because there are two surgical teams working 
simultaneously, one on the abdomen and the 
other on the chest. 
All inhaled anesthetics induce vasodilation 
in the skin by inhibiting central thermoregu-
latory control (Ozaki , Ozaki ). Iso-
fl urane has a more potent vasodilatory eff ect 
on skin blood fl ow than halothane (Mulhol-
land ). Th e thermoregulatory threshold 
is highest for nitrous oxide and halothane, 
and lowest for sevofl urane and isofl urane; an 
inverse correlation with the anesthetic dose 
has been found (Smith , Stoen ). 
Also intravenous propofol inhibits the cen-
tral thermoregulatory control, thus leading 
to redistribution hypothermia (Leslie , 
Matsukawa b). In addition, propofol 
produces a profound, peripheral arterial and 
venous dilation (Bently ), causing an 
increase in skin blood fl ow. Th e agent used 
for induction of anesthesia aff ects the degree 
of hypothermia developing during the op-
eration. Th e hypothermia is more profound 
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with intravenous propofol than with sevofl u-
rane inhalation as an induction agent (Ikeda 
). Patients developing even a short-
lasting propofol-induced vasodilation during 
the induction of anesthesia have developed a 
marked hypothermia compared with patients 
receiving inhalational induction with sevofl u-
rane (Ikeda ). Ketamine as an induction 
agent causes considerably less hypothermia 
than propofol (Ikeda ), as it is an arterial 
vasoconstrictor. Intraoperative thresholds for 
thermoregulatory vasoconstriction depend on 
the size, shape, and age of the patient, depth 
of anesthesia, degree of pain stimulus, and the 
method of temperature management. (Sessler 
, Sessler , Washington , Kurz 
, Xiong ,) 
In humans anesthesia mainly aff ects cutane-
ous blood fl ow, while subcutaneous blood fl ow 
remains virtually unchanged (Saumet ). 
2.4. Monitoring of blood fl ow 
in fl aps
2.4.1. Methods used to measure blood fl ow 
in surgical fl aps
Monitoring of blood fl ow in surgical fl aps is 
essential to detect any disturbances in fl ap vi-
ability. If signs of compromised blood fl ow are 
observed, urgent measures are taken to reper-
fuse the fl ap. An ideal monitor of fl ap perfusion 
is simple, reliable, reproducible, and sensitive 
and should give information about perfusion 
of the whole fl ap. A selection of methods has 
been developed for monitoring blood fl ow in 
fl aps. However, only a few methods are suitable 
for continuous clinical use in superfi cial and 
buried fl aps. Th e methods most widely used 
are presented in the next sections.
Th e simplest method to monitor the fl ap is 
clinical observation of fl ap color and capillary 
refi ll aft er gentle manual pressure. A pale color 
without capillary refi ll can indicate arterial in-
suffi  ciency and a blueish color with a very fast 
refi ll can be a sign of venous congestion. Stick-
ing the fl ap with a needle and observing the 
color of blood oozing from the pinprick holes 
can also be used as a simple monitor (Dagum 
). 
Temperature of the fl ap is an old method for 
monitoring fl ap blood fl ow in replanted body 
parts and fl aps. It is considered reliable in ideal 
circumstances (Sloan , Kaufman ) 
and is still a popular method for monitoring 
replanted digits. However, ambient tempera-
ture, core temperature, humidity, light, and 
vasomotor responses can aff ect surface tem-
perature, which has been found to react slowly 
when blood fl ow decreases. In buried fl aps, 
measuring the temperature diff erences be-
tween thermocouple probes placed proximally 
and distally to the anastomosis is considered 
more reliable than observing the surface tem-
perature (May ).
Several chemical techniques have been ap-
plied for monitoring of fl aps. Tissue perfusion 
can be estimated aft er an intravenous injec-
tion of fl uorescein (Lange , McCraw , 
Graham ). Adequately perfused tissue 
fl uoresces under ultraviolet light. Th e method 
is useful at the time of elevation of a skin-con-
taining fl ap, but it is suitable only for a single 
measurement in  hours, and is thought to 
underestimate the amount of surviving tissue. 
Continuous measurements can be performed 
with a fi ber-optic dermofl uorometer, which 
has been successfully used in monitoring 
perfusion of pedicled and free fl aps (Silver-
man , Casanova , Whitney ). 
Indocyanine green is also a fl uorescent dye with 
less side-eff ects than fl uorescein. It has given 
promising results in monitoring blood fl ow in 
fl aps (Eren ). Radioactive isotopes, includ-
ing technetium-m with a half-life of , 
hours, (Aygit ), xenon- with a half-life 
of , days (Tsuchida ), and sodium- 
with a half-life of , years (Harrison ), 
have been given to patients and the perfusion 
has been monitored with scintigraphy. Th ey 
can be used for monitoring perfusion in free 
and pedicled superfi cial and buried fl aps, but 
they are not suitable for continuous monitor-
ing. Hydrogen gas clearance gives repeated and 
quantitative measurements of tissue blood fl ow 
in buried and superfi cial fl aps (Aukland , 
Glogovac ).
Flap blood fl ow has been assessed with 
methods based on the tissue metabolism. Sub-
cutaneous and intramuscular pH measured 
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with implantable probes have decreased in 
fl aps with impaired blood fl ow as a conse-
quence of increased anaerobic metabolism 
(Raskin a). Microdialysis is a technique 
analyzing the metabolic activity of tissue by 
means of microdialysis catheters implanted in 
the tissue. Glucose, glycerol, lactate, and pyru-
vate concentrations can be measured from the 
dialysate. Th e method was initially used in 
brain monitoring, but it has been successfully 
applied in fl ap monitoring as well (Bito , 
Ungerstedt , Edsander-Nord , Setälä 
, Setälä ). In ischemic free fl aps, de-
creased glucose concentrations and increased 
lactate levels and lactate/pyruvate ratios have 
been observed (Udesen , Setälä ).
Near-infrared spectroscopy (NIRS) is a 
noninvasive continuous method of monitor-
ing blood fl ow of tissue. It was introduced ten 
years ago to monitor circulation in surgical 
fl aps (Hayden , Th orniley ). It mea-
sures the hemoglobin and oxyhemoglobin 
concentrations in tissue up to  cm in depth. 
Th e hemoglobin concentrations refl ect chang-
es in blood volume, thus indirectly indicating 
the amount of perfusion. NIRS has been able 
to diff erentiate between arterial, venous, and 
total vascular occlusion in fl aps (Irwin , 
Th orniley ). It is considered a promising 
tool for measuring perfusion in fl aps (Scheu-
fl er ). Photopletysmography estimates the 
fl uid volume of tissue by detecting diff erences 
in light absorption of the skin. Light emitted by 
a cutaneous diode probe is refl ected by hemo-
globin in the erythrocytes of dermal capillaries 
of the skin. Th e refl ected light is received by a 
photo detector and analyzed as light intensity 
along a frequency spectrum, with the noise re-
moved. Th e method can diff erentiate between 
perfused and nonperfused tissue and provides 
a good estimate of pedicle vessel patency (Stack 
). Newer modifi cations have been devel-
oped using a green-light emitting diode, giving 
an accurate estimate of possible fl ap ischemia 
(Futran ).
Th e Doppler eff ect has been widely used 
for measuring the velocity of blood fl ow since 
the s (Strandness ). Th e main modi-
fi cations are the Doppler ultrasonography and 
the laser Doppler fl owmetry (LDF). Th e LDF 
is explained in detail in the next sections. In 
conventional Doppler ultrasonography, the 
probe emits ultrasounds to a tissue up to sev-
eral centimeters in depth, and the sound waves 
refl ected from blood cells in large arteries and 
veins are analyzed. Th e blood fl ow in arteries 
and veins has a typical signal, being triphasic 
in arteries and lower pitched and continuous 
in veins. When blood fl ow in a vessel decreas-
es, the signal changes. When monitoring fl ap 
pedicles, the adjacent large vessels from other 
tissues may disturb the accuracy of the ultra-
sound Doppler signal. Miniature implantable 
Doppler probes attached to a thin cuff  fi tting 
around an effl  uent vein or distally to the arte-
rial anastomosis have been developed to over-
come this problem (Swartz , Swartz , 
Kind ). 
Th e measurement of local partial pressure 
of oxygen is a popular way to observe blood 
fl ow in fl aps. It can be measured on the surface 
of the fl ap with a transcutaneous oxygen tension 
monitor (PtcO) or inside the tissue with an im-
plantable tissue oxygen tension probe. PtcO is 
explained in detail later in the text. Tissue oxy-
gen tension monitoring has been developed 
since s (Hunt , Chang ), gradu-
ally becoming a popular monitor of local brain 
blood fl ow in neurosurgery and neurocritical 
care (Dings ). It is considered a reliable 
method for continuous monitoring of blood 
fl ow in superfi cial and buried fl aps as well (Ma-
honey , Hirigoyen ).
Laser Doppler fl owmetry
Th e laser Doppler fl owmeter is a continuous 
monitor of microcirculation. It was introduced 
about  years ago following the development 
of laser technologies and fi ber-optic systems 
(Stern , Holloway , Nilsson a, 
Nilsson b). Th is method of measuring cu-
taneous blood fl ow is based on the frequency 
shift  of the laser light. A monochromatic He-
Ne laser beam is emitted through an optical 
fi ber on the skin surface where it permeates 
the skin to a depth of ,– mm. Th e thickness 
of the epidermis, the most superfi cial layer of 
skin, is ,–, mm and the thickness of the 
dermis below is ,– mm. Th e LDF beam is 
assumed to reach the dermis, and, in some cas-
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es, the subcutaneous layer under the dermis. 
When the laser beam hits moving blood cells 
in the blood vessels, the frequency of refl ecting 
laser light is spectrally broadened, while the 
frequency of light refl ected from static tissues 
does not change. A photodetector in the LDF 
probe receives the backscattered light beams, 
which are processed by the instrument, and the 
result is produced as a low-noise input signal 
linearly related to the number and velocity of 
moving blood cells in the measured fi eld at low 
or moderate fl ow rates (Nilsson b, Ten-
land , Bengtsson , Svensson ). 
Th e LDF output signal is presented in arbitrary 
perfusion units, which is a relative value. Th e 
signal can be expressed as a continuous oscil-
lating line in a pen-recorder. 
Initially, LDF could only be used for moni-
toring the skin, including the capillary loops of 
the dermal plexus, with a skin probe, but today 
a variety of diff erent probes are available, in-
cluding implantable miniprobes for monitor-
ing diff erent tissues, e.g. the muscle of buried 
fl aps, and probes with diff erent fi ber separa-
tions suitable for monitoring vascular beds at 
diff erent depths. 
Th e traditional LDF measures the blood 
fl ow at a single point, and repeated measure-
ments give the trend in the perfusion at this 
determined site. Recently, a new development 
of LDF has been made, enabling blood fl ow in 
a larger area to be measured continuously. Th e 
laser Doppler perfusion imaging (LDPI) is a 
noncontact two-dimensional system, where 
the laser beam scans a horizontal area with the 
help of mirrors integrated in the probe system, 
and processes an image containing at least  
measurement sites. LDPI gives quantitative 
information on a specifi c region of interest 
(Essex , Wårdell ) and has proven to 
be a useful and reliable monitor of perfusion 
in dermatology, plastic surgery, diabetology, 
and wound healing (Arnold , Fullerton 
).
LDF is generally considered a good indica-
tor of changes in blood fl ow in clinical plastic 
surgery (Heden , Svensson a, Svens-
son b, Yuen , Heller ), although 
some authors have been sceptical (Walkinshaw 
, Banic , Hickerson ). It is ac-
cepted that the variable to be monitored is the 
trend in perfusion and not the absolute value 
given by the monitor. It has been suggested 
that if the relative fl ow of a fl ap falls to    
of its initial fl ow for more than  minutes, 
the fl ap should be aggressively observed, and 
in cases with very low LDF readings the fl ap 
should be immediately explored (Heller ). 
LDF is used for postoperative fl ap monitoring 
in many centers. 
Th e LDF value is infl uenced only minimally 
by wide diff erences in oxygen tensions. Th e 
LDF level varies greatly between diff erent indi-
viduals and also between diff erent measuring 
sites in one person (Tenland ), but the cu-
taneous LDF values for the same donor tissues 
have been similar between several volunteers 
(Goldberg ). Daily LDF variations of –
   occur frequently. A LDF value measured 
continuously or repeatedly at exactly the same 
site in a person is considered reliable (Tenland 
). Th e reliability of the LDF signal is af-
fected by improper attachment or movement 
of the probe, location of the probe over a larger 
vessel, or technical problems in the apparatus 
or the laser beam (Heden , Clinton , 
Svensson ). 
Transcutaneous oxygen tension 
PtcO is among the oldest methods for fl ap 
monitoring (Achauer , Harrison , Se-
rafi n , Svedman , Smith ). PtcO 
is an indirect indicator of blood fl ow, refl ecting 
oxygen delivery and consumption in the skin 
(Achauer ). Th e method measures the 
oxygen tension of skin through a permeable 
membrane. Th e probe heats the skin to a tem-
perature of about . °C to induce maximal 
vasodilation to minimize the arterial-to-skin 
surface oxygen gradient. 
Th e probe requires calibration against an 
oxygen-free zero solution and ambient pres-
sure before each measurement and a stabi-
lization period of – minutes aft er each 
replacement. PtcO is a little lower than arte-




2.5.1. Endothelin and vasoconstriction
Endothelin- (ET-), described in , is one 
of the most potent vasoconstrictors (Yanagi-
sawa ). It is a -amino acid polypeptide 
mainly synthesized and secreted by vascular 
endothelial cells (Yanagisawa , Remuzzi 
). Stimuli inducing the production of 
endothelin include cold, thrombin, increased 
transmural pressure, stretch, hypoxia, and 
decreased shear stress on the vascular lining 
(Yanagisawa , Yoshizumi , Gandhi 
). Th e vasoconstrictory eff ect of ET- ap-
pears to be mediated via the ET-A receptors 
situated in smooth muscle cells, while the ET-B 
receptors are situated in vascular smooth mus-
cle cells and endothelial cells; they also medi-
ate the vasodilatory eff ects of ET-, depending 
on the balance between vasoconstriction and 
vasodilation (Seo , Mickley ). Th e 
binding of ET- to smooth muscle cells causes 
a prolonged vasoconstriction (Remuzzi ), 
which is intense in arteries and even stronger 
in veins (Cocks ). ET--induced vasocon-
striction results in an increase of blood pres-
sure, but ET- does not aff ect heart rate (Re-
muzzi , Gandhi ). It is involved in the 
control of cardiovascular function by mainte-
nance of vascular tone in man (Remuzzi , 
Haynes ). 
ET- is a local hormone and more than 
   of its secretion from the endothelium 
is towards the underlying muscle and not to-
wards the vessel lumen. Plasma ET- concen-
tration is thought to increase only when very 
high amounts of ET- are released from the 
tissues (Remuzzi , Gandhi ). Plasma 
ET- concentrations of .– pg/ml have been 
detected in healthy humans (Karwatowska-
Prokopczuk ). Elevated ET- levels have 
been observed during surgery (Hirata ) 
and aft er major operations (Shirakami ).
2.5.2. Effect of different substances on 
endothelin levels
In experimental and clinical studies, plasma 
endothelin release and subsequent vasocon-
striction have been suppressed by calcium an-
tagonists (Kiowski , Liu , Kobayashi 
, Yakubu ). Th e dihydropyridine 
calcium channel antagonist nicardipine, and 
the angiotensin-converting enzyme (ACE) in-
hibitor enalapril suppress plasma-ET- levels 
in hypertensive patients with type  diabetes 
(Iwase ). Felodipine is a dihydropyridine 
calcium antagonist with a powerful vasodila-
tory capacity. It reduces peripheral resistance 
by relaxing arterial resistance vessels with-
out causing negative inotropic eff ects (Ljung 
). Before the studies of this thesis, no 
reports of its eff ects on ET- levels had been 
published. 
ET- production has also been suppressed 
by statins, which inhibit ET- production at 
the level of gene transcription (Hernández-
Perera ), by ET-A-receptor antagonists 
(Liu ), and by nonselective ET-A/ET-B 
antagonists such as bosentan (Kiowski , 
Sutsch ).
2.5.3. Endothelin and surgical fl aps
Studies on surgical fl aps indicate that endothe-
lin may be an important regulator of the mi-
crocirculation and aff ect the development of 
tissue necrosis. In dogs, intra-arterial infusion 
of ET- reduced blood fl ow in skin fl aps (Sam-
uelson ). Intraperitoneal injection of ET- 
has decreased the length of skin fl ap survival in 
rats (Tane ). 
Th e relation of ET- levels and ischemia 
has been investigated in experimental fl aps. 
Elevated plasma ET- levels have been mea-
sured in ischemic island epigastric fl aps (Mat-
suzaki , Hjortdal , Pang ,) and 
increased levels of ET- have been found on 
vascular walls of the pedicles of isolated free 
fl aps submitted to prolonged ischemia (Pang 
). Progressive venous stasis has induced 
greater production of ET- than arterial isch-
emia (Menger ). 
ET- concentration of the blood fl owing 
from the pedicle vein of free TRAM or DIEP 
fl aps has been evaluated in  women. ET- 
concentration increased during the operation 
in fl aps, but not in peripheral blood (Lantieri 
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). Th e concentration of ET- in diff erent 
parts of experimental random pattern skin 
fl aps has been investigated. In the early post-
operative hours, the highest levels of ET- 
have been measured in the proximal fl ap (Tane 
, Inoue ). ET- is speculated to re-
strict blood fl ow by inducing vasospasm on the 
proximal parts of the fl ap (Inoue ). In one 
study, endogenous ET- level was highest in 
the proximal fl ap for the fi rst  hours, there-
aft er gradually decreasing, and increased in 
the fi rst week in the distal fl ap. Th e distal ET- 
level correlated with the incidence of necrosis 
(Mobley ).
In experimental fl aps, administration of an 
ET-A receptor antagonist FR- (Tane 
, Inoue ) and a combined ET-AB re-
ceptor antagonist tezosentan (Erni ) has 
improved postoperative fl ap blood fl ow and 
fl ap survival. A recent study shows, however, 
that the increasing eff ect of ET-A antagonist 
BQ- or ET-AB antagonist PD- on 
fl ap blood fl ow is not seen until – days aft er 
fl ap elevation (Wettstein ). In the same 
experimental study, administration of an ET-B 
antagonist BQ- increased tissue survival 
signifi cantly. An increase in fl ap blood fl ow 
was observed on the fi rst day aft er fl ap eleva-
tion (Wettstein ). 
2.6. Effect of different interven-
tions on blood fl ow in the fl ap
Several interventions have been attempted to 
prevent ischemia and improve blood fl ow in 
fl aps, especially in high-risk patients. Th e delay 
procedure means restricting of fl ap blood fl ow 
before the planned reconstruction to produce, 
in the distal portions of the fl ap, moderate 
ischemia, which does not cause necrosis. Th is 
method is a type of ischemic preconditioning. 
Th e delay procedure is performed one to four 
weeks before the fi nal operation date by elevat-
ing part of the fl ap, but leaving the pedicle un-
cut or by ligating one of the pedicles in fl aps 
with more than one dominant pedicle. Selec-
tive embolization of one of the pedicles has 
also been succesfully used as a delay procedure 
in pedicled TRAM fl aps (Scheufl er ). A 
delay procedure in TRAM fl aps was suggested 
by Hartfampf in his initial publication (Har-
trampf ). Surgical delay of a fl ap has been 
shown to lead to dilation of the choke vessels 
between adjacent territories. It is a permanent 
and irreversible event, with a maximal eff ect 
between  and  hours aft er raising the fl ap 
(Dhar ). Incidence of necrosis was sig-
nifi cantly lower in pedicled TRAM fl aps with 
ligation of the superfi cial and deep inferior 
epigastric arteries one month before the recon-
struction than in fl aps without the delay proce-
dure (Ribuff o ). 
To fi nd a pharmacologic agent capable of 
preventing or reducing fl ap ischemia, many 
substances have been investigated. A variety 
of sympatholytics, vasodilators, calcium chan-
nel blockers, rheologic agents, prostaglandin 
inhibitors, anticoagulants, glucocorticoids, 
and free radical scavengers have had little or 
no eff ect on fl ap blood fl ow or development 
of necrosis (Vedder ). Recently promis-
ing results have been observed in experimen-
tal studies where vascular endothelial growth 
factor (VEGF) was given preoperatively as 
subdermal gene therapy in experimental skin 
fl aps. Th e increase in fl ap blood fl ow caused 
by VEGF is thought to be mediated by nitric 
oxide (Huang ). Th e role of endothelin re-
ceptor antagonists in augmenting fl ap viability 
is discussed in Section ..
2.6.1. Calcium antagonists and 
cutaneous blood fl ow 
Calcium channel blockers are vasoactive 
agents capable of decreasing sympathetic tone 
and producing arteriolar smooth muscle relax-
ation. Th ey block the adrenergically mediated 
vasoconstriction by inhibiting the fl ux of cal-
cium ions into vascular smooth muscle cells. 
Whether denervation changes the eff ect of 
calcium channel blockers on vascular smooth 
muscle, is unknown. Th e density of dihydro-
pyridine calcium channel blocker binding sites 
was decreased to almost one-third of its normal 
value aft er denervation in vas deferrens of rats 
(Jurkiewicz ), but in another study dener-
vation increased the eff ect of calcium channel 
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blockers nifedipine and cobolt in slow skeletal 
muscles in frogs (Vasquez ). Th is topic has 
not been investigated in humans. 
Felodipine is a vascular selective dihydro-
pyridine calcium channel blocker with no di-
rect eff ect on cardiac contractility or conduc-
tion at therapeutic dosages. It dilates peripheral 
resistance arterioles, but has no eff ect on veins. 
It lowers arterial blood pressure by reducing 
peripheral resistance without causing negative 
inotropic eff ects. Felodipine is a more power-
ful vasodilator than verapamil, diltiazem, or 
nifedipine (Ljung ). Th e dosage used in 
treatment of hypertension is – mg once 
daily. In healthy subjects,  mg of felodipine 
causes an increase in forearm blood fl ow and a 
decrease in forearm peripheral resistance (Ag-
ner ). 
Topical nifedipine has reduced the inci-
dence of necrosis in experimental random 
pattern skin fl aps (Davis ). Oral dihydro-
pyridine calcium antagonists have reduced the 
incidence of necrosis in some experimental 
studies (Hira , Pal , Yessenow , 
Bailet ), but contradictory results have 
also been reported (Miller , Emery ). 
Dihydropyridine calcium antagonists, e.g. 
amlodipine, felodipine, nisoldipine, and nife-
dipine, have been able to inhibit ET--induced 
vasoconstriction in some clinical and experi-
mental studies (Kiowski , Liu ). Th e 
eff ect of felodidipine on blood fl ow or necrosis 
in fl aps has not been reported before the stud-
ies presented in this thesis. 
2.7. Effect of overweight 
on fl ap blood fl ow 
2.7.1. Measurement of obesity 
Body mass index 
Body mass index (BMI), calculated as weight 
(kg) / height (m), has traditionally been con-
sidered a reliable index of relative body weight 
(Keys ). Th e widely used classifi cation of 
obesity based on BMI is presented in Table V 
(Krotkiewski , Poirier ). Obesity is 
defi ned as BMI greater than the th percentile 
or a body weight    over ideal body weight. 
Severe obesity is defi ned as BMI greater than 
the th percentile or body weight    over 
the ideal weight (Najjar , Choban ). 
Waist-hip circumference ratio
Body fat distribution can be described with 
the waist-hip circumference ratio (WHCR) 
(Lapidus , Soler ). WHCR is the ratio 
between waist circumference and hip circum-
ference. Waist circumference should be mea-
sured with the patient standing, at the border 
of the lowest third of the distance between the 
xiphoid process and umbilicus, and hip cir-
cumference about  cm below the anterior iliac 
spine (Lapidus ). 
In women, upper body obesity has been as-
sociated with cardiovascular problems (Lapi-
dus ) and increased peripheral vascular 
resistance (Jern ). WHCR > . is con-
sidered upper body type, WHCR .–. 
medium type and WHCR < . lower body 
type fat distribution (Soler ). According to 
the criteria of the World Health Organization 
(WHO), WHCR > . in men and > . in 
women denotes abdominal obesity (National 
Institutes of Health ). 
Measurement of thickness of 
fat with ultrasonography
Ultrasonography is a convenient, noninvasive 
method for imaging soft  tissues without radia-
tion exposure. It has been used for measuring 
the thickness of subcutaneous fat (Katch , 
Ramirez , Suzuki , Orphanidou ) 
and muscles (Hides ). Th e thickness of 
subcutaneous fat of the TRAM fl ap area, and its 
relation to cutaneous necrosis have been inves-
tigated (Yano ). In that study, the average 
subcutaneous fat thickness over the abdomen 
correlated with BMI. Th e subcutaneous fat 
thickness could be estimated to some extent by 
BMI with the exception of some patients with 
high BMI, who had a large amount of visceral 
fat but only moderatel subcutaneous fat. Ac-
cording to the same study, abdominal fat thick-
ness is not a risk factor for necrosis of pedicled 
transverse rectus abdominis musculocutane-
ous fl aps in patients who are thin, average, or 
only mildly obese (Yano ).
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2.7.2. Overweight and complications 
in TRAM fl aps 
Overweight is associated with an increased 
risk of comorbidities (Poirier ) and com-
plications related to surgical procedures (Ab-
del-Moneim , Choban ). Obesity of 
the patient may cause several complications at 
the donor site and in the fl ap itself, probably 
because of cardiovascular problems (Lapidus 
). 
High rates of fl ap and donor-site morbidity 
have been observed in obese patients who un-
derwent breast reconstruction with a pedicled 
TRAM fl ap (Holmström , Hartrampf , 
Kroll , Berrino , Watterson , 
Spear ). Th ese complications include total 
fl ap loss, fl ap hematoma, fl ap seroma, mastec-
tomy skin fl ap necrosis, donor-site infection, 
donor-site seroma, and abdominal hernia. 
Many authors have considered obesity a rela-
tive contraindication to breast reconstruction 
with a pedicled TRAM fl ap (Schefl an a, 
Hartrampf ). 
Th e free TRAM fl ap has been recommend-
ed instead of the pedicled TRAM fl ap for obese 
patients and other high-risk patients such as 
heavy smokers (Watterson , Paige , 
Chang a). Obesity has, however, also been 
associated with increased complication rates in 
free fl aps, and is suggested to be a relative con-
traindication to free TRAM fl ap reconstruc-
tion as well (Grotting , Schusterman , 
Grotting , Kroll , Schusterman , 
Schusterman , Selber ).
In a retrospective review of  free TRAM 
fl ap breast reconstructions, overweight (BMI 
–,) and obese (BMI –,) patients 
had signifi cantly more fl ap and donor-site com-
plications than patients with an ideal weight. 
However, the majority of overweight and even 
obese patients were treated succesfully. Th e au-
thors state that the surgeon and patient must 
be aware of the possible association between 
obesity and complications. According to this 
study, morbidly obese (BMI > ) patients 
should avoid any type of TRAM fl ap breast re-
constructions (Chang b).
Th e outcomes of pedicled and free TRAM 
fl aps in relation to weight were compared in 
a retrospective study. Of the  patients,  
were obese (BMI > ,). Th e overall compli-
cation rate was similar in pedicled and free 
TRAM fl aps. An increased complication rate 
was observed in free TRAM fl aps of severely 
obese (BMI ≥ ,) women and in pedicled 
fl aps of obese (BMI ,–) smokers. Th e 
overall complication rate correlated with BMI 
in free but not in pedicled TRAM fl aps. Th is 
study indicates that both the pedicled and free 
TRAM fl aps can be used successfully in obese 
patients, bearing in mind the possibility of 
complications (Moran ). 
2.7.3. Overweight and cutaneous necrosis 
in surgical fl aps 
Obesity of the patient may pose a risk to the 
viability of the TRAM fl ap. Th e probable un-
derlying causes are vascular problems (Lapidus 
) and the stretch caused by the heavy fl ap 
on musculocutaneous perforator vessels nour-
ishing the fl ap (Schefl an ). Consequently, 
obesity has been considered a relative con-
traindication to breast reconstruction by some 
authors (Schefl an a, Hartrampf , 
Grotting ). 
In pedicled TRAM fl aps, obesity has in-
creased the risk of cutaneous necrosis in several 
studies (Berrino , Moran , Ducic , 
Spear ), but some authors have reported 














Krotkiewski 1983 < 19 19–24 25–27 28–30 Obesity > 30
Poirier 2006 < 18.5 18.5–24.9 Overweight 25–29.9 30–34.9 35–39.9 > 40
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no eff ect (Kroll ). Fat necrosis has been ob-
served in pedicled fl aps of obese patients more 
oft en than in fl aps of patients with ideal weight 
(Berrino ). In free TRAM fl aps, the risk of 
cutaneous necrosis increased in some studies 
(Selber ), while other studies found no ef-
fect (Chang b, Moran ).
In a retrospective study of  pedicled 
TRAM fl aps, obese patients (BMI > ) had an 
increased risk for cutaneous necrosis compared 
with patients with normal weight or over-
weight (Spear ). In a retrospective survey 
of  free TRAM fl aps, the incidence of fat or 
cutaneous necrosis was not increased in over-
weight and obese patients (Chang b). In a 
retrospective comparison of outcomes of  
pedicled and free TRAM fl aps in patients with 
BMI > ., cutaneous necrosis was more com-
mon in pedicled fl aps than in free fl aps. Th e 
average BMI was  in patients with pedicled 
fl aps and  in those with free fl aps. Th e in-
cidence of fat necrosis was equal for both fl ap 
types (Moran ). Prospective studies on the 
eff ect of obesity on fat or cutaneous necrosis in 
TRAM fl aps, except for Study V in this thesis, 
have not been reported. 
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3 Aims of the study
Th e purpose of this study was to obtain new knowledge about microcircula-
tion and the TRAM fl ap during breast reconstruction.
Th e study focused on the following questions:
. What kind of perioperative changes are measured with LDF and PtcO 
in the cutaneous blood fl ow of pedicled and free TRAM fl aps for breast 
reconstruction (I, II)? 
. Can postoperative development of cutaneous necrosis be predicted in 
pedicled TRAM fl aps with perioperative LDF or PtcO measurements (I)? 
. What kind of changes occur in the plasma concentrations of ET- during 
and aft er prolonged plastic surgical operations (TRAM fl ap being used as an 
example)? Can any association be found between the ET- concentrations 
and peripheral vasoconstriction, changes in blood pressure and heart rate, 
and development of cutaneous or fat necrosis (III)? 
. Can preoperatively administered felodipine, a vasodilating calcium 
antagonist, cause changes in plasma ET- release and degree of 
vasoconstriction perioperatively, or cutaneous blood fl ow and development 
of cutaneous necrosis in a free TRAM fl ap postoperatively (IV)? 
. Is there any association between the indices of obesity and the postoperative 




Th is clinical investigation was performed on 
 women undergoing a breast reconstruction 
with a TRAM fl ap at the Department of Plastic 
Surgery, Helsinki University Central Hospital, 
in –. Th e purpose and nature of the 
study were explained to the patients before 
obtaining their informed consent. Th e study 
protocols of all investigations were approved 
by the Ethics Committee of Töölö Hospital and 
the protocol of Study IV also by the Finnish 
National Agency for Medicines. Th e work con-
sisted of fi ve studies (I–V). Th e characteristics 
of the patients are shown in Table VI.
During Study II four patients with breast 
reconstruction using a “supercharged” TRAM 
fl ap, i. e. a pedicled TRAM fl ap with an addi-
tional anastomosis to the vessels in the thora-
cal area, were also evaluated. 
In Study I two patients had hypertension re-
quiring medication, and one also had hypothy-
reosis. In Study II, one patient took medication 
for hypertension and one for hypothyreosis. 
In Study V, one patient took aspirin and gold 
for rheumatoid arthritis with mild symptoms. 
Otherwise, all the patients were considered 





Fift een consecutive females scheduled for 
breast reconstruction were enrolled in this 
prospective study. 
Changes in the cutaneous blood fl ow of a 
pedicled TRAM fl ap were investigated with 
LDF and PtcO at ten predetermined times pe-
rioperatively and on the fi rst, third, and seventh 
postoperative days (Table VII). Th e patients 
were observed for development of cutaneous 
necrosis during the one-week hospital stay.
Study II
In this prospective study, the cutaneous blood 
fl ow of a free TRAM fl ap was evaluated in  
women with breast reconstruction. Th e skin 
blood fl ow was measured with LDF and PtcO 
at the same preoperative and intraoperative 
predetermined times as in Study I, and on the 
third postoperative day. 
Measurements were also taken from the 
four women with a pedicled TRAM fl ap with 
an additional microvascular anastomosis of 
the inferior epigastric vessels. 
Wound healing was observed clinically and 
4 Patients and methods
Table VI. Characteristics of patients in Studies I–V.
Study I II III IV V
Number of patients 15 11 10 1 20 12 1
Age, years 46 (31–61) 46 (32–59) 47 (31–60) 46 (34–59) 9 (31–60)
Weight, kg 64 (52–76) 66 (52–85) 65 (47–74) 64 (50–85) 63 (47–74)
Height, cm 163(158–173) 165 (160–175) 164 (147–171) 164 (156–169) 163 (147–171)
Time from mastectomy, years 4.8(1,5–7) 6.2(2–19) 4.2 (2,5–11) N/A 3.7(2,5–11)
Duration of operation, minutes. 284(225–330) 396(312–510) 282 (230–360) 291(225–460) 280(230–360)
Smokers 1/15 0/11 2/10 7/20 1/12
1 Nine of the patients were the same in Studies III and V. N/A Not reported. The data are represented as arithmetic means (range).
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an ultrasound investigation was performed on 
the reconstructed breast during the hospital 
stay in order to detect any signs of fat necrosis.
Study III 
Ten women undergoing a pedicled TRAM fl ap 
reconstruction were investigated in a prospec-
tive manner in order to determine whether 
plasma ET- concentration has any role in the 
vasoconstriction that develops during long-
lasting operations. Plasma ET- concentra-
tions, forearm-fi nger temperature gradient 
(Tgrad), rectal temperature (Trect), mean arte-
rial pressure (MAP,) and heart rate (HR) were 
measured at nine predetermined times before, 
during, and aft er the operation (Table VIII). 
Wound healing was observed in the same way 
as in Study II.
Study IV
Th e eff ect of felodipine on plasma ET- levels, 
peripheral vasoconstriction, and fl ap survival 
was examined in a randomized, double-blind, 
and prospective setting in  women sched-
uled for breast reconstruction with a free 
TRAM fl ap. Th e patients were randomly allo-
cated to receive either felodipine (Plendil® As-
tra Zeneca, Sweden)  mg or a placebo tablet 
perorally on the preoperative evening and in 
the morning before the operation. Th e baseline 
values of MAP and HR were measured, and 
a blood sample was drawn for plasma ET- 
determination on the preoperative day on the 
ward. Tgrad, MAP, and HR were measured and 
blood for ET- determination was sampled on 
the operation day at the same measuring times 
as in Study III (Table VIII). Postoperatively, on 
the ward, blood was sampled for plasma ET- 
determinations on the fi rst, second, and sixth 
postoperative days. To assess cutaneous blood 
fl ow of the TRAM fl ap area, PtcO was mea-
sured on the fl ap marked on the abdominal 
skin preoperatively and one hour aft er arrival 
in the recovery room, on the fi rst, second, and 
sixth postoperative days on the fl ap at its fi nal 
site. All measurements were performed on the 
ipsilateral (the side with the rectus muscle) and 
contralateral sides of the vertical skin area of 
the fl ap. Wound healing was observed clini-
cally.
Study V
Th e association of degree and type of obesity 
with outcome of the pedicled TRAM fl aps for 
breast reconstruction was evaluated in  
women. Th e study was planned to be per-
formed partly on the same patients as in Study 
III. One of the ten patients in Study III refused 
to take part in Study V, and so nine patients 
were the same in Studies III and V. 










1 On preoperative day   I, II I, II
2 Patient anesthetized, before incision I, II I, II I, II I, II
3 Contralateral side of fl ap elvated I, II I, II I, II
4 Whole fl ap elevated and rectus muscle cut I, II I, II  I, II
5
Inferior epigastric artery ligated (I) or superior 
pedicle ligated (II)
I, II I, II I, II
6
Inferior epigastric vein ligated (I) or fl ap on 
the chest, before anastomosis (II)
I, II I, II I, II
7 Recovery room I, II I, II I, II I, II
8
On fi rst postoperative day (I)









9 On third postoperative day I I I I
10 On seventh postoperative day I I I I
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On the preoperative day, weight was esti-
mated by measuring body mass index (BMI), 
and type of body fat distribution by waist-hip-
circumference ratio (WHCR). Th ickness of the 
abdominal fat over the rectus muscle was mea-
sured by ultrasonography on the preoperative 
day and at one week, six weeks, three months, 
and nine months postoperatively.
Survival of the TRAM fl aps was evaluated 
clinically during the hospital stay and at the 
outpatient visits at the same time-points as the 
ultrasonography measurements were made. 
Signs of fat necrosis were noted during the ul-
trasonography investigations.
4.2.2. Anesthetic management
Th e patients were operated on under general 
anesthesia as recommended for microvascu-
lar and fl ap surgery at the time of Studies I–V 
(Robins , Macdonald ). Th e patients 
were premedicated with  mg of diazepam 
approximately  minutes before induction 
of anesthesia. Aft er intravenous boluses of 
fentanyl . mg, glycopyrronium . mg, and 
precurarization with pancuronium  mg, an-
esthesia was induced with thiopentone  mg/
kg. Suxamethonium –. mg/kg was adminis-
tered to facilitate tracheal intubation. Anesthe-
sia was maintained with    inhaled nitrous 
oxide and .–   isofl urane in oxygen. Th e 
aim was to maintain systolic blood pressure at 
– mmHg during dissection of the fl ap 
and at about  mmHg aft er the fl ap had been 
transferred to the mastectomy wound and/
or the anastomoses were fi nished. Th e lungs 
were ventilated mechanically to normocapnia 
(exhaled end-tidal carbon dioxide concentra-
tion at about   ) with a Servo  ventilator 
(Siemens-Elema, Sweden). Neuromuscular 
block was produced with pancuronium – mg 
as needed aft er a bolus of . mg/kg. Fentanyl 
was given in doses of .–. mg. At the end 
of the operation, neuromuscular block was an-
tagonized with neostigmine . mg and glyco-
pyrronium . mg. Isofl urane and nitrous oxide 
inhalation were discontinued aft er the wounds 
had been bandaged. Th e trachea was extubated 
when spontaneous ventilation was adequate. 
Hydroxyethyl starch     (Plasmafusin, 
Leiras-Kabi Infusion Oy, Vantaa, Finland) ( 
ml) was given aft er induction, and Ringer’s ac-
etate was infused to maintain a stable hemo-
dynamic state and mild hypervolemic hemodi-
lution. Hematocrit (packed cell volume) was 
kept at .–., and transfusion was given 
as needed. Dextran  ( ml) (Rheomacro-
Phase 
(Study III)
Measuring time ET-1 Tgrad Trect MAP HR PtcO2
On preoperative day IV IV IV IV
1 Before induction of anesthesia III, IV III, IV III, IV III, IV
2 1 hour after induction of anesthesia III, IV III, IV III, IV III, IV III, IV
3 3 hours after induction of anesthesia III, IV III, IV III, IV III, IV III, IV
4 At end of operation III, IV III, IV III, IV III, IV III, IV
5 10 minutes after arrival in recovery room III, IV III, IV III, IV III, IV III, IV
6 30 minutes after arrival in recovery room III, IV III, IV III, IV III, IV III, IV
7 1 hour after arrival in recovery room III, IV III, IV III, IV III, IV III, IV  IV
8 2 hours after arrival in recovery room III, IV III, IV III, IV III, IV III, IV
9 3 hours after arrival in recovery room III, IV III, IV III, IV III, IV III, IV
On fi rst postoperative day IV IV
On second postoperative day IV IV
On sixth postoperative day IV IV
Table VIII. The measuring times in Studies III and IV.
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the umbilicus and the lower border above the 
suprapubic area. A schematic representation of 
the surgical procedures is provided in Figure  
at the Review of the Literature section.
Pedicled TRAM fl aps (I, III, V)
Th e rectus muscle and pedicle on the opposite 
side to the mastectomy area were used. Th e half 
of the fl ap situated contralaterally to the rectus 
abdominis muscle and mainly below the um-
bilicus was fi rst elevated as far as the linea alba. 
Th e ipsilateral (over the rectus muscle) side 
of the TRAM fl ap was then dissected, leaving 
three centimetres of the anterior rectus sheath 
on the fl ap. Th e rectus abdominis muscle was 
cut above the arcuate line. At this stage, the 
fl ap had a double circulation through the in-
ferior and the superior epigastric vessels. Next, 
the DIEA was ligated and then the vein. Th e 
fl ap was tunnelled under the upper abdomi-
nal skin to the mastectomy wound. Th e breast 
was shaped by rotating the fl ap   °C so that 
the medial side of the breast represented the 
random side of the fl ap. Th e distal portion of 
the random side (zone IV) was discarded. Th e 
abdominal wall was reconstructed without for-
eign material using nonabsorbable continuous 
sutures to the fascia. 
Free TRAM fl aps (II, IV)
Th e rectus muscle and pedicle on the opposite 
side to the mastectomy area were used. Th e 
contralateral side of the fl ap was fi rst elevated 
to the linea alba. Th e ipsilateral side (situated 
over the rectus muscle) of the TRAM fl ap was 
then dissected. Next, . cm of the anterior 
rectus sheath and  cm of the rectus muscle 
were taken above the arcuate line to the fl ap. 
A lateral strip (. cm in width) of the rectus 
muscle was left  in place to avoid contraction 
of the muscle edges. Th e rectus muscle was cut 
below the deep inferior epigastric pedicle. Th e 
rectus muscle was then cut at a level below the 
umbilicus, and the superior epigastric pedicle 
was ligated. Th e DIEA was dissected down to 
the external iliac vessels. Th e pedicle was about 
 cm long. Th e deep inferior epigastric vessels 
were then ligated, and the fl ap was without 
perfusion. Th e abdominal wall was closed by 
nonabsorbable sutures. Th e assistant dissected 
dex, Kabi Infusion A/S, Norway) was infused 
aft er the operation until the next morning. All 
infusions were given via venous cannulas in 
the upper extremity on the side opposite the 
operative side. 
Intraoperative heat loss was prevented by 
warming the infusion bags in water at   °C 
before the infusion started. Ambient tem-
perature was maintained at approximately –
  °C during the operation and in the recovery 
room. Skin-surface warming devices were not 
used during operation, except for a water-fi lled 
warming mattress intraoperatively.
In the recovery room, the patients breathed 
room air during the measurements in Studies I 
and II. At all other times the patients breathed 
   oxygen via a face mask in the recovery 
room. Oxycodone in intravenous doses of . 
mg/kg was given for pain relief. Th e need for 
pain medication was assessed by experienced 
anesthesia nurses. No other medication was 
given in the recovery room. On the ward pre-
operatively and postoperatively, the patients 
breathed room air. Analgesics were given as 
needed on the postoperative days. 
Electrocardiogram, heart rate, intra-arte-
rial pressure, pulse oximetry, urinary output, 
end-tidal carbon dioxide concentration, and 
inspiratory oxygen concentration were moni-
tored continuously throughout the anesthesia. 
Neuromuscular block was monitored with a 
nerve stimulator. A cannula was inserted in the 
radial artery of the arm with the infusion can-
nula for continuous blood pressure monitoring 
and for taking blood samples. 
4.2.3. Surgical technique
Th e same surgeon (SAS), as the head of the 
team, elevated all the fl aps using a standardized 
technique and performed all the anastomoses 
in free fl aps. Th e fl ap was designed and drawn 
on the skin surface on the preoperative day. All 
TRAM fl aps were formed of the rectus muscle 
and vessels opposite to the mastectomy side and 
a symmetric elliptic area of skin and subcutis 
around and below the umbilicus. Th e height of 
the skin island varied from  to  cm, the 
upper border of the fl ap being slightly above 
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the scar at the chest wall and the skin to the 
inframammary fold. 
Th e recipient vessels in the axilla were ex-
posed. Th e deep inferior epigastric pedicle was 
anastomosed end-to-end either to the thora-
codorsal vessels or to the scapular circumfl ex 
vessels. Th e free TRAM fl ap was placed on the 
chest wall, the umbilicus caudally and the con-
tralateral side of the fl ap side medially. Exces-
sive skin and subcutis were removed, and the 
breast was shaped. 
Pedicled TRAM fl aps with the additional 
microvascular anastomosis (II)
Th ese four pedicled TRAM fl aps were elevated 
in the same way as the regular pedicled TRAM 
fl aps, and the deep inferior epigastric pedicle 
was dissected and ligated (phase a). Th e fl ap 
was pulled to the thoracic wall (phase ). Th e 
inferior epigastric vessels were anastomosed 
end-to-end to the thoracodorsal vessels ( cas-
es) or the scapular circumfl ex vessels ( case) 
in the axilla.
4.2.4. Measurements
Cutaneous blood fl ow
Th e cutaneous blood fl ow of the TRAM fl ap 
was monitored with LDF in Studies I and II 
and with PtcO in Studies I, II, and IV. Th e in-
spired oxygen concentration was    during 
the pre- and postoperative LDF and PtcO mea-
surements,    intraoperatively, and    
during an oxygen stimulation test in Study I. 
Sterility of the LDF and PtcO probes was main-
tained during the operation.
LDF (I, II)
Th e LDF values were measured with a laser 
Doppler fl owmeter (Perifl ux B, Perimed, 
Stockholm, Sweden) at times shown in Table 
VII. A standard probe was used. One probe 
holder was attached with a double-sided 
sticker on the axial (ipsilateral) side and one 
on the random (contralateral) side of the fl ap 
skin, both the same distance from midline, ap-
proximately – cm depending on the form of 
the fl ap (Fig. ). Each measurement lasted for 
at least  minutes. 
Th e measurements were made at the prede-
termined times shown in Table VII. Th e fi rst 
measurement was performed aft er the patient 
had been anesthetized. Th e probe holders were 
then detached during skin disinfection and 
later attached at exactly the same sites. Aft er 
this the probe holders remained attached at the 
sites until the last measurement on the third 
(II) or the seventh (I) postoperative day. 
Figure 7. LDF and PtcO2 measurement sites on the TRAM fl aps, with the fl ap at its original site (A) and on the 
chest (B). The black circles represent the sites of the LDF probes and the white circles the sites of the PtcO2 probes. 
The measuring sites were the same in free and in pedicled (in this picture) TRAM fl aps.
A B
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PtcO2 (I, II, IV)
PtcO of the TRAM fl ap skin was measured with 
a transcutaneous oximeter (Transcom , 
Novametrix Medical Systems, Inc., CT, USA). 
Th e measurement sites were on the ipsilateral 
side, over the rectus muscle of the TRAM fl ap, 
and on the contralateral side of the fl ap, about 
 cm cranially to the LDF measurement sites 
on both sides of the fl aps (Fig. ). 
Th e measurements were made using one 
probe, which was moved to the other mea-
suring sites according to the study protocol. 
Before the fi rst measurement and before each 
replacement, the PtcO probe was calibrated 
against an oxygen-free zero solution and ambi-
ent pressure. Th e temperature of the probe was 
. °C. Th e skin seemed to tolerate the heat-
ing well since no burn injuries were observed 
on the skin under the probe. 
In Studies I and II, the PtcO measurements 
were performed at the times shown in Table 
VII. On the operation day, the ipsilateral and 
contralateral values were obtained aft er the 
patient was anesthetized (phase ) and in the 
recovery room. Between phases  and , the 
PtcO probe was left  on the contralateral side 
and kept in place. Th e ipsilateral values were 
not measured from phase  to phase  due to 
the time-consuming calibration needed before 
each replacement of the probe. Aft er the op-
eration, the PtcO values were taken from both 
sides of the fl ap. 
In Study IV, PtcO was measured from the 
ipsilateral and contralateral sides of the TRAM 
fl ap at the times shown in Table VIII. 
An oxygen stimulation test was performed 
in Study I aft er each postoperative measure-
ment, with the patient breathing    oxygen 
for  minutes. A minimum rise of    in the 
PtcO value was considered a positive result in 
the oxygen test.
Temperature measurements (I–IV)
Rectal and peripheral temperatures were 
measured with thermocouple probes (Exacon 
MC , Exacon, Copenhagen, Denmark). 
Th e patients had received laxatives to empty 
the rectum for the surgery. Aft er induction of 
anesthesia, the rectal temperature (Trect) probe 
was inserted about – cm and taped in 
place. In Studies I and II, the peripheral tem-
perature (Tperiph) was measured from the index 
fi nger of the mastectomy side. In studies III 
and IV, probes for skin temperature measure-
ments were attached on the radial side of the 
middle third of the antebrachium (Tant) and 
on the tip of the index fi nger (Tind) of the arm 
on the mastectomy side. No intravenous fl uids 
were infused in the arm with the peripheral 
temperature probes. 
Th e baseline values of Trect were recorded 
immediately aft er the induction of anesthesia, 
and the baseline values of the peripheral tem-
peratures (Tperiph, Tant and Tind) before the induc-
tion of anesthesia.
In Studies I and II, Trect and Tperiph were 
measured continuously during the operation. 
Th e values at phases  and  and at the end of 
the operation were included in the study. In 
Studies III and IV, the thermoregulatory vaso-
constriction was evaluated as the temperature 
gradient (Tgrad) between Tant and Tind (Tant–Tind) 
(Stoen ). Tgrad was measured continuously 
during the operation, and the perioperative 
values were included in the studies as shown in 
Table VIII. Tgrad exceeding   °C was considered 
signifi cant degree of vasoconstriction.
Th e arm on the mastectomy side was cov-
ered with a cotton sheet during the operation. 
Th e rest of the patient was covered with dou-
ble-thickness cotton drapes. In the recovery 
room, the arm with the measurement probes 
was exposed; otherwise, the patient was cov-
ered with a hospital blanket and a sheet. 
Plasma ET-1 determinations (III, IV)
In Studies III and IV, blood samples for ET- 
determinations were taken at the times shown 
in Table VIII. In Study III, before induction of 
anesthesia, a  G venous cannula was inserted 
without local anesthesia into a cubital vein of 
the arm on the side of the removed breast to 
obtain blood for the plasma ET- determina-
tions. Th e cannula was closed with an obtura-
tor while not in use. In Study IV, on the preop-
erative day on the ward, a venous blood sample 
was drawn from the cubital vein for plasma 
ET- determination before the blood pressure 
measurement. In the perioperative period, ar-
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terial blood samples for ET- determinations 
were collected at the times shown in Table VIII. 
In Study IV, samples for the ET- determina-
tions were obtained from venous blood on the 
postoperative days.
Ten milliliters of blood was drawn into ice-
chilled tubes containing  mM (fi nal concen-
tration) NaEDTA and carried immediately to 
the laboratory. Plasma was separated by cen-
trifugation at  °C and stored at – °C until 
assayed for ET-.
Radioimmunoassay of ET- was performed 
as described earlier (Fyhrquist ) using 
ET- and ET- antiserum generated in rabbits. 
Th e antiserum showed    cross-reaction 
with ET- and ET- and < .   cross-reaction 
with the –, –, and – sequences 
of preproendothelin and with big ET-, se-
quences – and –. 
Before ET- radioimmunoassay, plasma 
samples were purifi ed using Bondelut C-
OH analytical columns. One milliliter of 
plasma was acidifi ed with    acetic acid and 
applied on a column. Aft er the samples had 
been washed with distilled water, the absorbed 
peptide was eluted with    ethanol and    
acetic acid. Th e eluted fraction was lyophilized 
and dissolved into assay buff er,  mM buff er 
pH ., containing  mM NaEDTA, . nM 
cystine, .   merthiolate, .   bovine se-
rum albumin, and .   triton x-. Radio-
immunoassay was performed using sequential 
incubation by adding I-labelled ET- on the 
third day. Bound ligands were separated on 
the fourth day using the second antibody tech-
nique. Th e sensitivity of the assay was . pg / 
tube, and the recovery of ET- added to plasma 
was   . For external control, in each ET- 
radioimmunoassay three samples of pooled 
normal human plasma containing , , or  
pg of human ET- were measured. 
Hemodynamic measurements and 
other blood samples (I–IV)
HR and MAP values registered at the times 
shown in Table VIII were included in Stud-
ies III and IV. On the preoperative day on the 
ward, blood pressure (noninvasive blood pres-
sure monitor) and HR were measured with the 
patient seated. Th e perioperative MAP values 
were obtained from the indwelling catheter in 
the radial artery. 
Blood was sampled for arterial oxygen ten-
sion (PaO) determinations in Study I at phase 
, three hours aft er the induction of anesthesia, 
in the recovery room, and during the oxygen 
stimulation test. In Study II, PaO was deter-
mined at phases  and . In Study III, arterial 
samples for PaO determinations were taken 
one and three hours aft er induction of anesthe-
sia and  minutes aft er arrival in the recovery 
room, and in Study IV three hours aft er induc-
tion and  minutes and two hours aft er arrival 
in the recovery room.
Blood for hematocrit determinations was 
sampled in all studies as needed to maintain 
the desired level of hemodilution. In Study III, 
the hematocrit values determined at the same 
times as PaO, and in Study IV the values ob-
tained preoperatively and two hours aft er ar-
rival in the recovery room were included in the 
study. 
Assessment of weight (V)
On the preoperative day, the weight and the 
type of body fat distribution was estimated by 
measuring BMI and WHCR. BMI is calculated 
as weight (kg) / height  (m). WHCR is the ratio 
between waist circumference and hip circum-
ference. Waist circumference was measured 
with the patient standing, with a tape measure, 
at the border of the lowest third of the distance 
between the xiphoid process and umbilicus, 
and hip circumference was measured about 
 cm below the anterior iliac spine (Lapidus 
). 
Th ickness of the abdominal fat and the 
rectus abdominis muscle of the fl ap area were 
measured by ultrasonography. All ultasonog-
raphy measurements were made by the same 
radiologist. Aloka SSD  ultrasonography 
equipment (Aloka Co. Ltd., Japan) with a . 
MHz surface probe was used for the measure-
ments. Th e margins of the TRAM fl ap were 
drawn on the abdominal skin on the preop-
erative day. Th e ipsilateral side of the fl ap was 
divided into fi ve equally long segments on its 
long axis, and the thickness of the subcutane-
ous fat was measured at these four points. Th e 
maximal thickness of the underlying rectus 
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abdominis muscle on the ipsilateral side was 
measured at three points: on the top and bot-
tom margins of the fl ap and at the midpoint 
between them. Postoperatively, the same mea-
surements were made at one week, six weeks, 
three months, and nine months, at the same 
sites of the fl ap, and the patients were inter-
viewed and examined. Possible complications 
were also analyzed. A clearly increased signal 
intensity of the fat tissue in ultrasonography 
was regarded as a sign of fat necrosis. 
4.2.5. Statistical analyses
Studies I and II
Th e LDF values were obtained in arbitrary 
units. Because of the wide variation between 
LDF values measured from diff erent persons 
and diff erent sites of the same person (Tenland 
), the LDF values taken at each site are 
presented as a percentage of the reference val-
ue of that measuring site. Th e values measured 
at phase  (I, II) are regarded as the reference 
values of the LDF and PtcO measurements. 
Th e measured values are expressed as 
mean ± SEM (I) or mean ± SD (II). Th e statisti-
cal signifi cance of diff erences between means 
was tested using Student’s t-test for dependent 
and independent series (I). Th e statistical diff er-
ences between the measuring times within one 
group were analyzed with the nonparametric 
Wilcoxon-Pratt test. Diff erences between the 
free TRAM fl aps and the pedicled TRAM fl aps 
with additional anastomosis were tested with 
a two-sample rank-sum test (Mann-Whitney 
test) (II). 
Study III 
Parametric data are given as mean ± SD and 
nonparametric data as median (–   
quartiles). Th e statistical analysis for diff er-
ences between the measuring times was per-
formed with the Wilcoxon-Pratt test. Nonlin-
ear correlation between measured parameters 
was tested with the Spearman rank test.
Study IV
Th e data are given as means (   confi dence 
intervals (CI)). Characteristics of the patients 
are given as means (range). For comparison 
between the groups at each measuring time, 
diff erences of means (   CIs) were calculat-
ed. Statistical signifi cance was tested with the 
pooled variance t-test.
Study V
Patients were divided into groups depending 
on the BMI and WHCR as follows: BMI <  
= slightly underweight; BMI – = ideal 
weight; BMI – = slightly overweight; and 
BMI – = moderately overweight (Krot-
kiewski ), and WHCR < . = lower body 
type; WHCR .–. = medium type; and 
WHCR > . = upper body type fat distribu-
tion (Soler ). 
Abdominal fat thickness of each patient 
at every measuring time was calculated as a 
mean of the four measurements taken. Th e 
signifi cance of diff erences between the groups 
was tested with the Chi-square test. Statistical 
analysis of diff erences in the measured vari-
ables between the measurement times was 
made with the Wilcoxon-Pratt test and for dif-
ferences between the patients with and without 
necrosis with the Mann-Whitney test. P values 
of less than . were considered signifi cant.
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5.1. Perioperative changes of cutane-
ous blood fl ow in TRAM fl aps (I, II)
One patient was excluded from Study I because 
of technical problems in her LDF measure-
ments. Th us, the measurements of  patients 
are presented in this study. In Study II, there 
were technical problems in the LDF measure-
ments of one patient and her LDF measure-
ments were therefore excluded from the study. 
Other measurements in Study II are from all 
the  patients.
5.1.1. Cutaneous blood fl ow 
in pedicled TRAM fl aps (I)
LDF values
Th e changes in LDF values at the contralateral 
and ipsilateral measurement sites of the pedi-
cled TRAM fl aps are shown in Figure .
Elevation of the contralateral side of the 
TRAM fl ap (phase ) caused a signifi cant 
increase in the ipsilateral value from base-
line level (phase ). When the whole fl ap was 
elevated and the inferior part of the rectus 
muscle cut (phase ), the blood fl ow returned 
to baseline level on both sides. Aft er ligation 
of the inferior epigastric artery (phase ), the 
contralateral LDF value decreased signifi cantly 
to  ±    (p < .) and the ipsilateral value 
to  ±    of baseline level. Ligation of the 
vein (phase ) did not cause a change from 
phase  in LDF values. In the recovery room 
(phase ), the LDF values were contralaterally 
low,  ±    (p < .) of the reference value, 
and ipsilaterally near baseline level. On the 
fi rst (phase ), third (phase ), and seventh 
(phase ) postoperative day, the LDF values 
were near baseline level on contralateral and 
ipsilateral sides of the fl ap. 
PtcO2 values
Th e PtcO values at the contralateral and ipsilat-
eral measurement sites of the pedicled TRAM 
fl aps are shown in Figure .
On the preoperative day (phase ), PtcO 
was ± mmHg on the contralateral and 
5 Results
Figure 8. LDF values as a percentage of the initial value (phase 2) on the ipsilateral and contralateral sides of the 
14 pedicled TRAM fl aps. ** represents p < 0.01 and *** p < 0.001 for difference from the initial value on each side 
of the fl ap. Measuring times as in Table VII. Values represent mean ± SEM.
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 ±  mmHg on the ipsilateral side the fl ap. 
When the patient was anesthetized (phase ), 
PtcO increased signifi cantly contralaterally 
and ipsilaterally. PtcO was measured only con-
tralaterally between phases  and . When the 
contralateral side of the fl ap was elevated, the 
contralateral PtcO returned to  ±  mmHg. 
It decreased signifi cantly compared with the 
baseline to  ±  mmHg when the whole fl ap 
was elevated and the rectus muscle cut (phase 
). When the pedicle artery (phase ) and vein 
(phase ) were cut, contralateral PtcO stayed 
Figure 10. LDF values as a percentage of the initial value (phase 2) at the ipsilateral and contralateral measuring 
sites of 10 free TRAM fl aps. * represents p < 0.05 for differences from the initial value on each side of the fl ap. 
Measuring times are as in Table VII. Values are given as mean ± SD.
Figure 9. Changes in transcutaneous oxygen 
tension (PtcO2) at the ipsilateral and contralateral 
measurement sites of the 14 pedicled TRAM fl aps. 
** represents p < 0.01 and *** p < 0.001 for difference 
from the initial value (phase 1) on each side of the 
fl ap. § represents p < 0.01 for differences between the 
ipsilateral and contralateral sides at each measuring 
time. Measuring times as in Table VII. Values represent 
mean ± SEM.
at  ±  mmHg. In the recovery room (phase 
), the contralateral PtcO was  ±  mmHg 
and ipsilateral PtcO  ±  mmHg. On the fi rst 
(phase ), third (phase ), and seventh (phase 
) postoperative day, the contralateral and 
ipsilateral PtcO values were low, but increased 
slowly towards the end of the study period. 
During phases , , , and  the ipsilateral 
PtcO values were signifi cantly higher than the 
contralateral values. All values measured dur-
ing phases – diff ered signifi cantly from the 
initial contralateral and ipsilateral values.
Stable oxygenation of the patients was 
maintained throughout the operation. PaO 
was  ±  mmHg one hour aft er induction 
of anesthesia,  ±  mmHg three hours aft er 
the induction,  ±  mmHg in the recovery 
room with the patient breathing room air, and 
 ±  mmHg in the recovery room during 
the oxygen stimulation test.
5.1.2. Cutaneous blood fl ow 
in free TRAM fl aps (II)
LDF values
Changes in LDF values on the contralateral 
and ipsilateral measurement sites of the free 
TRAM fl aps are shown in Figure .
Elevation of the contralateral side of the 
TRAM fl ap (phase ) caused an increase in the 
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contralateral and ipsilateral LDF levels. When 
the whole fl ap was elevated and the inferior 
part of the rectus muscle cut (phase ), the 
blood fl ow decreased contralaterally signifi -
cantly compared with phase  to  ±    of 
the initial value (p < .) and remained ip-
silaterally at  ±   . Aft er ligation of the 
superior epigastric pedicle (phase ), the LDF 
values remained stable. When the inferior 
pedicle was also cut and the fl ap was without 
circulation and lift ed to the chest (phase ), the 
LDF value decreased contralaterally signifi -
cantly to  ±    (p < .) and ipsilaterally 
to  ±   . In the recovery room (phase ), 
the LDF values had returned to the baseline 
level. On the third (phase ) postoperative day, 
the LDF values had increased further, contral-
aterally to  ±    and ipsilaterally signifi -
cantly to  ±    (p < .). 
PtcO2 values
Th e PtcO values at the contralateral and ipsi-
lateral measurement sites of the  free TRAM 
fl aps are shown in Figure .
Th e preoperative PtcO was contralaterally 
 ±  mmHg and ipsi laterally  ±  mmHg 
(phase ). Aft er induction of anesthesia (phase 
), PtcO increased signifi cantly both contra-
laterally and ipsilaterally. Aft er elevation of 
the contralateral side of the fl ap (phase ), the 
contralateral PtcO fell to the initial level. Th e 
ipsilateral PtcO was not measured in phases 
–. Th e contralateral PtcO decreased to 
 ±  mmHg when the whole fl ap was dis-
sected and both pedicles were intact (phase ). 
When the fl ap was without perfusion in phase 
, the contra lateral PtcO fell to  ±  mmHg 
(p < .). In the recovery room (phase ), 
the contralateral PtcO was  ±  mmHg (p 
< .) and the ipsilateral PtcO  ±  mmHg. 
On the third postoperative day the contralat-
eral and ipsilateral PtcO was still low compared 
with the baseline values.
Th e LDF and PtcO values of the four pa-
tients with the pedicled TRAM fl ap and an 
additional microvascular anastomosis in Study 
II are given in Table IX. Th ere were too few pa-
tients for us to be able to draw any statistical 
conclusions.
Figure 11. Transcutaneous oxygen tension (PtcO2) at 
the ipsilateral and contralateral measuring sites of 11 
free TRAM fl aps. * represents p < 0.05 for differences 
from the initial value on each side of the fl ap. 
Measuring times are as in Table VII. Values are given 
as mean ± SD.
Table IX. Contralateral and ipsilateral LDF and PtcO2 values of the patients with a pedicled TRAM fl ap with 
an additional microvascular anastomosis (n = 4). Values are given as mean ± SD.
LDF (% of initial value) PtcO2 (mmHg)
contra ipsi contra ipsi
Phase 1 51 ± 6 45 ± 1
Phase 2 100 100 64 ± 26 42 ± 24
Phase 3 260 ± 255 163 ± 47 47 ± 37
Phase 4 77 ± 56 83 ± 21 14 ± 16
Phase 5a 54 ± 30 73 ± 30 10 ± 18
Phase 6 77 ± 59 76 ± 17 0 ± 0
Phase 7 236 ± 258 93 ± 36 20 ± 18 23 ± 13
Phase 8 145 ± 70 158 ± 56 19 ± 13 32 ± 4
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5.2. Prediction of cutaneous 
necrosis in pedicled TRAM fl aps (I) 
During the hospital stay eight of the  patients 
with pedicled TRAM fl aps developed cutane-
ous necrosis, which was diagnosed clinically. 
Th e width of the necrosis varied between  and 
 mm. Th e two patients with a -mm-wide 
skin necrosis had other complications. One 
had a postoperative deep vein thrombosis, and 
liver metastases were detected later by ultra-
sonography. Th e other patient had received 
radiotherapy for spinal metastases three years 
earlier. On the postoperative days, she had 
marked postoperative atelectasis. Both of these 
patients were taking tamoxifen preoperatively. 
Th ree of the eight patients with skin necrosis 
needed a surgical revision. Th e smaller areas 
of necrosis healed spontaneously. No signifi -
cant diff erences existed between the patients 
with and without necrosis with regard to age, 
weight, height, duration of operation, transfu-
sions needed, or hemoglobin or arterial oxygen 
Figure 13. Changes in PtcO2 at the contralateral (A) and ipsilateral (B) measuring sites of the 14 pedicled TRAM 
fl aps in patients with and without cutaneous necrosis. * represents p < 0.05, ** p < 0.01, and *** p < 0.001 for 
difference between the patients with and without necrosis at each measuring time. Measuring times as in Table 
VII. Values are given as mean ± SEM.
Figure 12. LDF levels as a percentage of the initial value (phase 2) at the contralateral (A) and ipsilateral (B) 
measuring sites of the 14 pedicled TRAM fl aps in patients with and without necrosis.* represents p < 0.05 and 
** p < 0.01 for difference between the patients with and without necrosis at each measuring time. Measuring 
times as in Table VII. Values are given as mean ± SEM.
tension values. Th e only patient who smoked 
did not develop necrosis.
LDF values
Th e LDF values in the patients with and with-
out necrosis are shown in Figure . 
Th e contralateral LDF values were signifi -
cantly lower in the TRAM fl aps with necrosis 
than in the fl aps healing without complications 
in phase  ( ±    vs.  ±   , respectively, p 
< .), phase  ( ±    vs.  ±   , p < .) 
and phase  ( ±    vs.  ±   , p < .). 
Th e contralateral LDF values were lower in the 
necrosis group than in the non-necrosis group 
also during phases , , , , and , but the 
changes were not statistically signifi cant.
Th e ipsilateral LDF values were signifi cantly 
lower in the necrosis group than in the patients 
without necrosis during phase  ( ±    vs. 
 ±   , respectively, p < .) and phase  
( ±    vs.  ±   , p < .). No statis-
tically signifi cant changes occurred during 





Th e PtcO values in the patients with and with-
out necrosis are shown in Figure . 
Th e contralateral PtcO values were near 
zero aft er ligation of the artery (phase ) in 
the fl aps with necrosis and at a slightly higher 
level in fl aps without necrosis. Th e PtcO val-
ues in the necrosis group were signifi cantly 
lower than in the necrosis group during phase 
 ( ±  mmHg vs.  ±  mmHg, respectively) 
and phase  ( ±  mmHg vs.  ±  mmHg) 
(Fig.  A). 
Th e ipsilateral PtcO values were signifi cantly 
lower in the necrosis group than in the patients 
without necrosis during phase  ( ±  mmHg 
vs.  ±  mmHg, respectively), phase  ( ±  
mmHg vs.  ±  mmHg), and phase  ( ±  
mmHg vs.  ±  mmHg (Fig.  B). 
Th e oxygen challenge test was done at phas-
es –. Th e oxygen test was more oft en nega-
tive on the contralateral side of fl aps develop-
ing cutaneous necrosis than in fl aps without 
necrosis, but the diff erence was not statistically 
signifi cant. In the two patients with a -mm-
wide necrosis, the oxygen test was negative on 
both sides of the fl ap in all but one measure-
ment. 
5.3. Relation of plasma ET-1 con-
centrations to peripheral vasocon-
striction, blood pressure, heart rate, 
and cutaneous or fat necrosis (III)
Plasma ET-1 concentrations
In one of the ten patients in Study III, the plas-
ma ET- levels were exceptionally high at the 
three measurement times. Her highest ET- 
concentration was  pg/ml, – standard 
deviations above the mean of the plasma ET- 
levels of the other patients. A technical error in 
handling her ET- samples was suspected, and 
thus all data for this patient were excluded. Th e 
patient was a nonsmoker who had had a mas-
tectomy three years earlier and had received 
postoperative radiotherapy. Her fl ap healed 
without necrosis. Data of nine patients were 
included in the fi nal evaluation.
Th e preoperative plasma ET- concentra-
tions were . (.–.) pg/ml (median, 
– quartiles). At one and three hours aft er 
induction of anesthesia (phases  and ) and at 
the end of operation (phase ), they were sig-
nifi cantly lower, near  pg/ml on average. Ten 
minutes aft er the patients’ arrival in the recov-
ery room, plasma ET- concentrations were 
signifi cantly higher than at the end of opera-
Figure 14. Perioperative changes in forearm-fi nger 
temperature gradients (Tgrad) (difference between the 
skin temperatures of the antebrachium and index 
fi nger of the same arm). Values are given as median 
and 25–75 % percentiles. * represents p < 0.05 
compared with values measured before induction and 
† p < 0.01 compared with values at the end of the 
operation. Measurement times as in Table VIII.
Figure 15. Perioperative changes in mean arterial 
pressure (MAP, white squares) and heart rate (HR, 
black squares). Values are given as mean ± SD. * 
represents p <  0.05 compared with values measured 
before induction and † p <  0.05 compared with 
values at the end of the operation. Measurement 
times as in Table VIII.
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tion, but did not diff er signifi cantly from the 
concentrations before induction. Th ey stayed 
around  pg/ml until the end of the study. 
Peripheral vasoconstriction
Tgrad of . (.–.)  °C indicating vasocon-
striction was observed preoperatively. During 
the operation, Tgrad was negative, indicating va-
sodilation. Aft er the operation, vasoconstric-
tion developed again, Tgrad being at its highest 
one and two hours aft er the patients arrived in 
the recovery room (phases  and ). Th ereaft er, 
peripheral cutaneous vasoconstriction dimin-
ished, but some vasoconstriction was still ob-
served at the end of the study (Figure ).
Blood pressure and heart rate
During anesthesia, MAP was signifi cantly 
lower than before induction. Postoperatively, 
it diff ered from the pre-induction level only at 
two hours aft er arrival in the recovery room. 
All MAP values measured in the recovery room 
were signifi cantly higher than those measured 
at the end of the operation. HR remained at the 
pre-induction level during the operation. At all 
measurement times in the recovery room, it 
was signifi cantly higher than the level before 
induction and also the level at the end of the 
operation (Figure ).
Healing of fl aps
Four of the nine TRAM fl aps healed unevent-
fully. Th ere was minor skin necrosis in three 
fl aps and fat necrosis in two fl aps. Th e three fl aps 
with skin necrosis needed surgical revision. Th e 
fi nal result in all fl aps was satisfactory.
Correlation of ET-1 with measured 
parameters
In the nonparametric Spearman rank correla-
tion test, a statistically signifi cant nonlinear 
correlation existed between ET- and Tgrad (r = 
., p < .) and between ET- and MAP (r = 
., p < .), but not between ET- and HR. 
A statistically signifi cant nonlinear correlation 
was present between the preoperative Tgrad and 
development of necrosis (r= ., p <  .). No 
statistically signifi cant correlation was found 
between development of necrosis and intra- 
and postoperative Tgrad values or ET- levels. 
Figure 16. Perioperative changes in plasma ET-1 levels 
in the felodipine and control groups. Values are given 
as means (95  % CIs). The black squares represent the 
felodipine group and white squares the control group.
5.4. Effect of felodipine on plasma 
ET-1 concentrations, peripheral va-
soconstriction, postoperative PtcO2, 
and survival of free TRAM fl aps (IV)
Th e characteristics of the patients and opera-
tions were comparable within the groups. In 
the control group, one patient developed a 
postoperative hematoma necessitating surgical 
evacuation, one patient suff ered from pneu-
monia, and one patient had a postoperative 
pulmonary embolism. 
Plasma ET-1 concentrations
Th e preoperative plasma ET- concentrations 
were . (.–.) pg/ml (means,    CIs) in 
the felodipine group and . (.–.) pg/ml 
in the control group. No statistically signifi cant 
diff erences were present in ET- concentrations 
between the study groups at any measurement 
time (Figure ).
Temperature
Before induction of anesthesia, Tgrad was . 
(.–.)  °C in the felodipine group and . 
(.–.)  °C in the control group. Th ere were 
no statistically signifi cant diff erences in Tgrad 
between the study groups during the study 
period (Figure ). In both groups, Trect de-
creased during the fi rst hour of anesthesia and 
was at it lowest three hours aft er induction, 
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. (.–.)  °C in the felodipine group 
and . (.–.)  °C in the control group. 
It increased again in the recovery room, peak-
ing three hours aft er the operation to . 
(.–.)  °C in the felodipine group and 
. (.–.)  °C in the control group. No 
statistically signifi cant diff erences were ob-
served in Trect between the two study groups at 
any measurement time.
Blood pressure and heart rate
Th roughout the study period, HR was higher 
in the felodipine group than in the control 
group. Th e diff erence was statistically signifi -
cant before induction [. (.–.) beats 
per min (bpm) in the felodipine group and 
. (.–.) bpm in the control group, dif-
ference of means . (.–.), p < .] and 
 minutes aft er arrival to the recovery room 
[. (.–.) in the felodipine group and 
. (.–.) in the control group, diff er-
ence of means . (.–.), p < .]. 
Th e preoperative MAP was . (.–
.) mmHg in the felodipine group and 
. (.–.) mmHg in the control group. 
Th roughout the study period, no statistically 
signifi cant diff erences in MAP were observed 
between the groups.
Healing of fl aps
Th e ipsilateral and contralateral PtcO de-
creased in both groups from the initial  
mmHg to a lower level during the postopera-
tive period. Th e felodipine and control groups 
did not diff er statistically with regard to PtcO 
at any measurement time. In both groups, two 
of ten patients developed a minor cutaneous 
necrosis of the contralateral fl ap edge, which 
healed without surgical revision. In these pa-
tients, the contralateral PtcO was near zero in 
the recovery room and during the fi rst days 
on the ward. In the felodipine group, a statisti-
cally signifi cant diff erence was present in the 
contralateral PtcO between the patients with 
and without necrosis in the recovery room (p 
< .).
5.5. Effect of indices of obesity 
on cutaneous or fat necrosis in 
pedicled TRAM fl aps (V)
Six of the  patients had ideal relative body 
weight (BMI –), one was slightly under-
weight (BMI < ), three were slightly over-
weight (BMI –), and two were moderately 
overweight (BMI –). No patients in this 
study were obese (BMI > ). At the time of the 
study, marked obesity was considered a con-
traindication for TRAM fl ap breast reconstruc-
tion in Helsinki University Central Hospital. 
Based on WHCR, four patients had an upper 
type, two a medium type, and six a lower type 
body fat distribution.
Th ickness of the subcutaneous fat on the 
ipsilateral side of the pedicled TRAM fl ap was 
preoperatively . mm (mean) (range .–
.). One week aft er the operation, it had in-
creased signifi cantly to . mm (–.) (p 
< . compared with the preoperative level), 
remaining at this level for the remainder of the 
study period.
Of the  patients, four developed minor 
cutaneous necrosis on the edge of the contral-
ateral side of the TRAM fl ap and one developed 
fat necrosis seen on ultrasonography. Th ree of 
the patients with cutaneous necrosis needed 
surgical revision. Th ere were no signifi cant dif-
ferences in fat thickness between the patients 
with and without cutaneous or fat necrosis at 
any measurement time. 
No statistically signifi cant diff erences were 
present in development of necrosis between the 
groups based on BMI. Necrosis was more com-
Figure 17. The perioperative changes in Tgrad in the 
felodipine and control groups. Values are given as 
means (95  % CIs).
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mon in patients with a WHCR of less than ., 
i. e. in patients with a lower body type body fat 
distribution (four of six developed necrosis), 
than in patients with an upper or medium body 
type fat distribution. In patients with a WHCR 
of more than ., there were no cases of ne-
crosis. Th ese diff erences were not, however, 
statistically signifi cant (Table X a and b). 
Table X. Presence of cutaneous or fat necrosis in patients grouped (A) by body mass index (BMI) and (B) by 
waits-hip circumference ratio (WHCR).





WHCR Necrosis (n = 5) No necrosis (n = 7)





6.1. Perioperative changes of cutane-
ous blood fl ow in TRAM fl aps (I, II)
Breast reconstruction with the TRAM fl ap 
is performed on tens of thousands of women 
worldwide each year. Th e fairly common dis-
turbances in the fl ap’s cutaneous blood fl ow 
may lengthen the treatment, increase costs, 
and sometimes spoil the result of the opera-
tion. Before the studies presented in this thesis, 
the behavior of the cutaneous blood fl ow in 
diff erent phases of the TRAM fl ap operation 
was unknown. 
Th e temperature of the patient can aff ect 
cutaneous blood fl ow (Rowell , Boulant 
, Kellogg ). Temperature and fl ap 
blood fl ow are also connected to each other. 
In an experimental study on dogs, fl ap blood 
fl ow varied directly with temperature (Awwad 
). Moreover, hypothermia decreased blood 
fl ow in the rat epigastric fl ap (Kinnunen ). 
Th e changes measured in cutaneous blood fl ow 
in the studies of this thesis can be assumed not 
to have resulted from changes in the patient’s 
temperature, because during these studies the 
patients remained fairly normothermic due to 
the high ambient temperature ( °C), the use 
of a warming mattress, and warmed infusion 
fl uids. 
Anesthesia aff ects mainly cutaneous, not the 
subcutaneous blood fl ow in humans (Saumet 
). All inhaled anesthetics induce vasodila-
tion in the skin (Ozaki , Ozaki ). Th e 
vasodilatory eff ect of isofl urane is more potent 
than that of halothane (Mulholland ). In 
the present studies, the patients were anesthe-
tized with isofl urane. Th e decrease in LDF level 
aft er ligation of DIEA was likely not caused 
by the anesthesia itself. It has been observed 
experimentally that blood fl ow measured by 
LDF is maintained well during normovolemic 
conditions in musculocutaneous fl aps both 
with halothane and isofl urane anesthesia (Sig-
urdsson ). Our patients were kept mildly 
hypervolemic and hemodiluted in all studies, 
as recommended for microvascular surgery 
(Robins , Macdonald , Sigurdsson 
).
6.1.1. Pedicled TRAM fl aps (I)
Th e results of Study I show that the elevation 
of the contralateral side of the pedicled TRAM 
fl ap caused an increase in cutaneous blood 
fl ow, more clearly on the ipsilateral side of the 
fl ap. Before the operation, blood supply to the 
skin and subcutis of the TRAM fl ap area origi-
nated from the DIEA, whose branches run as 
paraumbilical and infraumbilical perforators 
through the rectus muscles to the vascular 
plexuses near the surface of the skin (Boyd 
, Moon ). When the contralateral 
side of the TRAM fl ap is elevated, the perfora-
tors rising from the underlying rectus muscle 
are ligated, and the natural route for cutane-
ous blood fl ow is lost. One would expect then 
a decrease in the cutaneous blood fl ow because 
aft er its elevation the contralateral skin and 
subcutis island receive blood only indirectly 
from the ipsilateral side through anastomotic 
channels in the subdermal plexus (Taylor 
) and distinct subcutaneous periumbili-
cal arteries (Kaufman ). However, in this 
study, hyperemia was observed with LDF when 
the contralateral part of the fl ap was elevated 
in pedicled TRAM fl aps. Th e signifi cant in-
crease in LDF level on the ipsilateral side could 
be caused by opening up of the choke vessels 
between adjacent vascular angiosomes, leading 
to increased blood fl ow from the SEA system 
(Taylor ). Opening of the arteriovenous 
shunts has been found aft er elevation of a 
myocutaneous rectus abdominis island fl ap in 
pigs (Hjortdal ). Our fi ndings suggest that 
the same phenomenon may occur in humans. 
6 Discussion 
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Some degree of hyperemia was also measured 
on the contralateral side of the fl ap. Th is might 
be the result of opening up of the para- and 
infraumbilical reduced-caliber choke vessels 
(Taylor ). Th e opening of the choke vessel 
may be stimulated by hypoxia caused by eleva-
tion of the contralateral side. 
A similar hyperemia was observed aft er el-
evation of musculocutaneous fl aps in dogs by 
Gottrup and coworkers (Gottrup ). Boyd 
and colleagues observed in a controlled experi-
mental study that a delay procedure, preopera-
tive ligation of SEA in TRAM fl aps, resulted 
in a postoperative increase in the amount of 
viable fl ap skin. Th e authors speculated that 
transient hypoxia resulting from ligation of 
SEA may play a role in triggering DIEA to 
take over some of the territory previously 
perfused by SEA (Boyd ). Later, the delay 
procedure was found to lead to dilation of the 
choke vessels between adjacent territories and 
not to ingrowth of new vessels (Dhar ). 
Ribuff o and coworkers used the study setting 
and protocol originally presented in Study I 
and measured blood fl ow with LDF and echo 
color-fl ow in pedicled TRAM fl aps. Th ey con-
fi rmed our results, showing hyperemia when 
the contralateral side of the pedicled TRAM 
fl ap is elevated (Ribuff o ).
In Study I, ligation of the DIEA caused a 
signifi cant decrease in LDF value on the con-
tralateral side. Skin blood fl ow on the con-
tralateral side of the fl ap did not return to the 
baseline until the fi rst postoperative day. Th e 
ipsilateral cutaneous blood fl ow remained near 
the baseline level at all postoperative measur-
ing times. Based on these results, the SEA ap-
parently cannot provide adequate perfusion to 
the contralateral skin paddle immediately aft er 
ligation of the DIEA, which is the dominant ar-
tery of the TRAM fl ap (Boyd , Hendricks 
). Th e return of LDF levels to the baseline 
on the postoperative days could be speculated 
to be a sign of SEA being able to increase blood 
fl ow in the fl ap gradually aft er the operation 
by keeping the choke vessels open. Th e origin 
of microvascular blood fl ow, previously from 
DIEA, must be reversed if the whole fl ap is to 
survive aft er the operation.
Soon aft er Study I Harris and coworkers 
published their report. Th ey demonstrated in 
an intraoperative investigation of  pedicled 
TRAM fl aps that occlusion of the SEA at the 
upper level of the skin fl ap caused a decrease 
in DIEA blood fl ow measured by ultrasound. 
Th ey assumed that survival of all lower TRAM 
fl ap tissues requires reversal of the direction of 
blood fl ow to the fl ap (Harris ), in accor-
dance with our opinion.
In this study, the contralateral PtcO fell to 
a very low level aft er the whole fl ap was ele-
veated and the DIEA was ligated. It remained 
near zero untill the seventh postoperative day, 
when the measurements ceased. Very low PtcO 
values have been found in surviving fl aps post-
operatively (Achauer , Svedman , 
Gottrup ). In , Raskin and his group 
and later Hjortdal and coworkers concluded 
that low PtcO levels measured aft er elevation 
of island fl aps were caused by decreased blood 
fl ow in the subdermal plexus. Th ey speculated 
that sympathetic denervation would stimulate 
opening up of the arteriovenous shunts and 
a decrease in blood fl ow in the most superfi -
cial cutaneous layers (Raskin b, Hjortdal 
). Th is could explain the very low PtcO 
values measured aft er DIEA ligation and dur-
ing the postoperative period in Study I. PtcO 
has been postulated to refl ect oxygen delivery 
and consumption in the skin, and low oxygen 
tension may be an indirect measure of in-
creased metabolic rate in the skin (Achauer 
). Low postoperative PtcO levels in these 
patients might also be a sign of increased con-
sumption of oxygen. Th e slow increase in PtcO 
during the postoperative week could indicate 
that a few days aft er the operation SEA is grad-
ually able to maintain blood fl ow also in the 
most superfi cial cutaneous layers.
Th e postoperative PtcO levels were con-
stantly lower on the contralateral side of the 
fl ap than on the ipsilateral side. Th is is prob-
ably caused for anatomical reasons, as the con-
tralateral side is postoperatively less perfused 
than the ipsilateral side due to cutting of the 
perforators during fl ap elevation.
Aft er this work, other studies have been 
conducted on the hemodynamics of pedicled 
TRAM fl aps. Codner and colleagues measured 
intravascular blood pressure of DIEA and the 
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corresponding vein before and aft er bipedicled 
TRAM fl ap breast reconstructions in patients 
with and without delay. Th ey observed an in-
crease in DIEA and vein blood pressure aft er 
transfer of the fl ap to the chest, indicating an 
increase in fl ap blood fl ow. Postoperatively, 
they observed a decrease in TRAM fl ap per-
fusion pressure in fl aps without delay and an 
increase in fl aps with delay (Codner ). 
Ribuff o and coworkers noted a similar decrease 
as in the present study in the contralateral LDF 
level of pedicled TRAM fl aps when the DIEA 
was ligated. Th ey also thought that this is due 
to blood fl ow inversion (Ribuff o ). In the 
studies of Clugston and coworkers, DIEA and 
the concomitant vein were cannulated. Th eir 
measurements showed that the venous pres-
sure increased and the perfusion pressure de-
creased when the fl ap was rotated to the chest 
(Clugston ). However, unlike in our study, 
they did not measure cutaneous blood fl ow.
Scheufl er et al have demonstrated by angiog-
raphy the opening of choke arteries between 
the superior and the deep inferior epigastric 
systems (Scheufl er ). In another recent 
study of  pedicled TRAM fl aps Scheufl er and 
associates found an increase in the systolic peak 
fl ow of the SEA early aft er surgery. Consistent 
with our view, they speculated that hypoxia in 
the fl ap tissue could lead to opening of choke 
arteries between the superior and deep inferior 
epigastric arteries (Scheufl er ). 
6.1.2. Free TRAM fl aps (II)
Cutaneous blood fl ow between pedicled and 
free TRAM fl aps was not compared in the 
same study. However, some conclusions be-
tween the pedicled fl aps in Study I and the 
free fl aps in Study II can be drawn, because the 
patients, operating conditions, anesthesia, and 
measurements were similar. 
On an anatomical basis, one might expect 
that cutaneous blood fl ow would be better in 
free than in pedicled TRAM fl aps since the free 
fl ap is supplied by the dominant pedicle of the 
TRAM fl ap, the DIEA (Boyd , Hendricks 
), and the pedicled fl ap by the nondomi-
nant pedicle, the SEA. Th e results of Studies I 
and II confi rm the clinical observations of the 
free TRAM fl ap demonstrating very few cir-
culatory complications. In Study II, only one 
of  patients developed a minor skin necrosis 
and one a fat necrosis, compared with Study I, 
where eight of  pedicled TRAM fl aps showed 
signs of minor cutaneous necrosis. Th e more 
reliable cutaneous blood fl ow in free fl aps has 
not been demonstated with hemodynamic 
measurements earlier in the literature. Nowa-
days the majority of TRAM fl ap breast recon-
structions are performed in Finland with a free 
TRAM fl ap and newer modifi cations such as 
the DIEP or SIEA fl ap. Pedicled TRAM fl aps 
are used in selected cases, especially outside 
microsurgical units.
In free TRAM fl aps, the ipsilateral and con-
tralateral LDF values increased, as in pedicled 
fl aps in Study I, during the elevation of the 
contralateral fl ap island and decreased to or 
below the initial level when the whole fl ap was 
elevated and the rectus muscle cut. Because 
the elevation procedures are rather similar in 
pedicled and free fl aps, no diff erences were 
expected. 
When the DIEA and vein were cut and the 
free fl aps were positioned on the chest, a sig-
nifi cant decrease in the contralateral PtcO and 
LDF levels was observed in free fl aps as a sign 
of reduction of blood fl ow. Th e LDF levels in 
the free fl aps did not decrease to zero, although 
the fl ap was without blood fl ow. LDF is unable 
to distinguish between nutrient and non-nu-
trient blood fl ow, and thus LDF seems to mis-
interpret the non-nutrient random movement 
of cells in a nonperfused tissue as blood fl ow 
(Marks ). 
In the recovery room, when the anastomo-
ses were functioning, ipsilateral and contralat-
eral LDF levels returned to baseline levels in 
the free fl aps. Th is result diff ers from the pedi-
cled fl aps, where the contralateral LDF levels in 
the recovery room were still signifi cantly lower 
than at the beginning of the operation. In the 
recovery room, the contralateral PtcO was low 
compared with the initial level in free fl aps, but 
had increased markedly compared with the 
values measured before the anasto moses were 
formed. Th e ipsilateral PtcO had increased to 
the preoperative level in the recovery room, 
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gradually exceeded the pedicled TRAM fl ap in 
popularity as a breast reconstruction method, 
despite the procedure being more demanding. 
Breast reconstruction with a pedicled TRAM 
fl ap can be performed with less microsurgical 
experience. If the pedicled TRAM fl aps prone 
to cutaneous necrosis could be identifi ed dur-
ing or immediately aft er surgery, some surgical 
or pharmacological interventions could be at-
tempted to enhance blood fl ow in the fl ap, and 
thus to increase the success rate.
In Study I, cutaneous necrosis was observed 
during the study period on the contralateral 
side of eight of the  the pedicled TRAM fl aps 
(  ), which is comparable with the indicence 
rates given in the literature (Hartrampf , 
Schusterman , Elliott , Kroll , 
Paige , Clugston , Garvey ). Fac-
tors known to increase the risk of cutaneous 
necrosis in pedicled TRAM fl aps are smoking 
(Chang a, Padubidri , Selber , 
Booi ) and obesity (Berrino , Moran 
, Ducic , Spear ). However, in 
Study I, only one patient smoked and her fl ap 
healed without complications. Th e weight of 
the patients did not diff er between the patients 
with and without cutaneous necrosis of the 
fl ap. 
Based on the results of Study I, intraop-
erative LDF measurements appear to be able 
to predict cutaneous necrosis of the pedicled 
TRAM fl ap. Th e contralateral LDF value aft er 
ligation of the DIEA decreased more in fl aps 
developing cutaneous necrosis than in fl aps 
healing uneventfully. Th e diff erence between 
the fl aps with and without necrosis remained 
signifi cant until the fi rst postoperative day. 
 Th e contralateral LDF level decreased aft er 
ligation of the DIEA to  ±    of the initial 
value in the fl aps developing cutaneous necro-
sis. Based on this fi nding, the pedicled TRAM 
fl aps prone to cutaneous necrosis can be iden-
tifi ed with intraoperative LDF measurements. 
It is important to be able to identify the fl aps 
susceptible to cutaneous necrosis during the 
operation because the surgical plan can still be 
changed from the pedicled fl ap to one with a 
more secure blood fl ow.
Later, in a retrospective study of  free 
fl aps, postoperative LDF identifi ed developing 
and on the third postoperative day it was near 
the initial level on both sides of the free fl aps. 
Th ese fi ndings diff er clearly from the pedicled 
TRAM fl aps (Study I) where the PtcO levels 
were very low throughout the postoperative 
period. Th e SEA apparently cannot perfuse 
the pedicled fl ap adequately on the fi rst days 
aft er the operation. Th ese results indicate that 
the postoperative blood fl ow in the free TRAM 
fl ap, measured by PtcO and LDF is more gen-
erous than in the pedicled fl ap. Th is phenom-
enon likely results mainly from the free fl ap 
being supplied by the dominant pedicle of the 
TRAM fl ap, the DIEA, while the nondominant 
pedicle SEA supplies the blood fl ow of the 
pedicled TRAM fl ap. 
Th e contralateral LDF and PtcO levels were 
constantly lower than the ipsilateral values at 
each measuring time in pedicled as well as in 
free TRAM fl aps. Th is result agrees with the 
anatomical fi ndings suggesting that the ipsi-
lateral cutaneous perfusion is superior to the 
contralateral blood fl ow (Dinner , Moon 
). Th e LDF and PtcO were measured at 
zones I and III; these zones are numbered ac-
cording to the original classifi cation of skin 
zones of the TRAM fl ap, where perfusion is 
best in zone I and worst in zone IV (Hartrampf 
, Schefl an a and b). Hallock has 
later investigated cutaneous blood fl ow intra-
operatively in free TRAM fl aps with LDF (Hal-
lock ). Th ey confi rmed the fi ndings of the 
present studies, showing that LDF levels were 
at all times higher on the ipsilateral than on the 
contralateral side of the TRAM fl ap skin. Th ey 
also revealed that the DIEA is the dominant 
source vessel of the TRAM fl ap compared with 
the SEA, as has been assumed based on ana-
tomical studies (Boyd , Hendricks ). 
Hallock and coworkers stated that a relative 
ischemia exists contralaterally even in free 
TRAM fl aps (Hallock ). 
6.2. Prediction of cutaneous 
necrosis in pedicled TRAM fl aps (I) 
According to clinical studies, cutaneous necro-
sis is more common in pedicled than free TRAM 
fl aps, which is why the free TRAM fl ap has 
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complications before they were clinically vis-
ible. If LDF level decreased to less than    of 
the baseline for  minutes or longer, aggressive 
exploration was considered necessary (Heller 
). In a recent study of muscle-sparing free 
TRAM fl aps, a lower blood fl ow was observed 
with LDF in zone IV of patients with fl ap com-
plications compared with patients without fl ap 
complications (Booi ). Th eir results are in 
accordance with ours. 
PtcO levels were signifi cantly lower in fl aps 
developing necrosis than in fl aps without 
necrosis contralaterally on the third and sev-
enth postoperative days and ipsilaterally at all 
postoperative measuring times. Development 
of necrosis could not, however, be predicted 
based on the intraoperative PtcO values.
An oxygen challenge test, a response of 
PtcO to increased inspired oxygen concentra-
tion, has been claimed to be a sign of intact 
circulation and fl ap survival (Achauer ). 
In the present study, a negative oxygen test was 
observed in the two patients with the broadest 
( mm) necrotic areas. In the other six pa-
tients with smaller necrotic areas, the oxygen 
test gave contradictory results. A possible ex-
planation for this is that the PtcO probes were 
not exactly over the contralateral edge (zone 
IV), where the necrosis developed, but were 
placed a little more centrally in the fl ap. 
If the fl aps at risk of developing cutaneous 
necrosis could be identifi ed intraoperatively 
with LDF, PtcO, or other monitoring methods, 
some approaches augmenting fl ap blood fl ow 
could be tried during the same operation. A 
new promising monitoring method is intra-
operative ICG fl uorescence video angiography, 
which has been used to visualize the individual 
perfusion map in pedicled TRAM fl aps. It might 
be useful for showing the area that should be 
discarded because of poor perfusion (Yamagu-
chi ). One attempt to improve fl ap blood 
fl ow has been to add a microsurgical anasto-
mosis to a pedicled TRAM fl ap (Harashina 
, Schefl an ). In Study II, we measured 
skin blood fl ow in four pedicled TRAM fl aps 
with an additional microvascular an astomosis 
in the axilla. In these four patients, the postop-
erative PtcO and LDF levels were higher than 
the levels in the pedicled fl aps in Study I, but 
lower than in the free fl aps of Study II. Th e 
number of patients is too low for drawing any 
conclusions. Various pharmacological agents, 
such as VEGF and endothelin antagonists 
(Tane , Inoue , Erni , Wettstein 
) have been applied to enhance fl ap blood 
fl ow, but usually these must be administered 
before the operation. An ideal agent could be 
administered to the patient at the moment that 
the risk for decreased fl ap fl ow is observed. 
Nitric oxide precursors administered during 
the operation have yielded promising results 
in preventing ischemia-reperfusion injury in 
myocutaneous fl aps of pigs (Cordeiro ). 
6.3. Relation of plasma ET-1 
concentrations to peripheral 
vasoconstriction, blood pressure, 
heart rate, and cutaneous or fat 
necrosis (III)
A long-lasting vasoconstriction is com-
mon during and aft er prolonged operations 
such as reconstructive procedures. Cutaneous 
vasoconstriction is known to depend on body 
temperature (Rowell , Boulant , Kel-
logg ). Th e role of ET-, a powerful vaso-
constrictory peptide secreted from endothelial 
cells, in development of intra- and postopera-
tive vasoconstriction remains obscure. In ex-
perimental studies, administration of ET- has 
reduced blood fl ow in skin fl aps (Samuelson 
, Inoue ) and decreased fl ap survival 
(Tane ). 
A relationship between plasma ET- con-
centrations and peripheral vasoconstriction 
was observed in this study. Th e increase of 
plasma ET- levels and Tgrad coinincided pre-
operatively and postoperatively. Elevated plas-
ma ET- concentrations have been measured 
during severe hemodynamic stress, myocar-
dial ischemia, sepsis, and trauma (Cernacek 
, Koller , Pittet ). Elevated ET- 
levels have also been observed during surgery 
(Hirata ). In Study III, slightly elevated 
plasma ET- levels were measured preopera-
tively and postoperatively. Th e highest values 
were noted before induction. Th e cause for the 
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increased preoperative ET- levels is unclear. 
ET- is known to be released as a result of hy-
poxia, stretch, increased intramural pressure, 
and cold (Gandhi ). Systemic hypoxia can 
be assumed not to be the cause for elevated 
ET- levels in Study III. Before induction, the 
patients’ peripheral oxygen saturation was 
normal, and the intra- and postoperative PaO 
levels were also within normal limits. A Tgrad of 
.  °C, indicating peripheral vasoconstriction, 
was observed preoperatively. Possibly, adren-
ergic stimulation following anxiety, despite 
benzodiazepine premedication, resulted in 
peripheral vasoconstriction, which could have 
induced peripheral hypoxia and hypothermia, 
leading to ET- release. Th e increase in the 
preoperative plasma ET- concentration could 
also have arisen from the pain due to insertion 
of the antecubital venous cannula, since local 
anesthesia was not used for the cannulation. 
Whether minor pain causes changes in ET- 
levels, is unknown. 
During the operation the ET- levels were 
within normal limits in Study III, around  pg/
ml. In the study of Shirakami and coworkers 
plasma ET- levels remained near preoperative 
values during minor surgery, including total 
knee replacement, cholecystectomy, or hys-
terectomy. During major operations, such as 
gastrectomy, esophagectomy, hepatectomy or 
heart surgery, ET- levels were higher than be-
fore the operation (Shirakami ). In Study 
III, the breast reconstruction with a pedicled 
TRAM fl ap could be assumed to be compa-
rable with the minor surgical procedures in 
which the ET- levels were not elevated in Shi-
rakami’s study. 
Peripheral vasoconstriction was not ob-
served one hour aft er the induction of anesthe-
sia. On the contrary, Tgrad was reduced, indicat-
ing vasodilation, which lasted throughout the 
operation. Th e vasoconstrictive eff ect of the 
high pre-induction level of plasma ET- on the 
microvessels may have been prevented with 
the use of isofl urane during anesthesia. Like all 
inhaled anesthetics, isofl urane inhibits central 
thermoregulatory control (Ozaki , Ozaki 
). Th e vasodilatatory eff ect of isofl urane 
is mediated by stimulating the β-adrenergic 
receptors of vascular smooth muscle (Philbin 
), but probably not by releasing nitric ox-
ide (Brendel , Johns ). Th e isofl urane-
induced vasodilation may have exceeded the 
vasoconstrictory eff ect of ET- during anes-
thesia. Moreover, if the initial ET- release was 
transient, it could have caused vasodilation by 
stimulating nitric oxide or prostacyclin release 
(Johns ). 
Postoperatively, an increase in the plasma 
ET- concentrations was measured ten min-
utes aft er arrival in the recovery room. Th e 
ET- levels in the recovery room remained 
slightly elevated, around  pg/ml, compared 
with the intraoperative levels. Elevated plasma 
ET- levels have been measured during the fi rst 
postoperative hours in several studies (Itoh 
, Miyaguchi , Sato ). In another 
study, increased ET- levels were observed 
postoperatively in patients receiving a knee ar-
throplasty. Th e maximal plasma ET- concen-
tration was measured . hours aft er the end 
of surgery, when ET- concentrations were . 
times the preoperative value (Matziolis ). 
In a study of elderly patients undergoing ma-
jor surgical procedures, the plasma ET- con-
centrations were elevated preoperatively and 
postoperatively in patients with hypertension 
compared with patients with normal blood 
pressure (Nelson ). ET- was not mea-
sured intraoperatively in that study. 
An increase in Tgrad as a sign of vasocon-
striction was measured as soon as the patients 
were transferred to the recovery room. Th e 
vasoconstriction disappeared by the end of 
the recovery room period. At the same time, 
plasma ET- concentrations were higher than 
during the operation. Th e postoperatively el-
evated plasma ET- concentrations appear to 
be associated with peripheral hypothermia. 
Th e peripheral vasoconstriction manifesting 
during the immediate postoperative hours may 
cause release of ET- from the peripheral parts 
of the body. Alternatively, surgical stress and 
manipulation of tissues have been suggested to 
induce increased ET- release aft er operations 
(Onizuka , Onizuka , Shirakami 
) and may have caused the peripheral va-
soconstriction. 
A statistically signifi cant correlation ex-
isted between plasma ET- concentrations 
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and MAP. Th e elevated ET- values pre- and 
postoperatively were accompanied by rather 
high MAP levels. Th is result is in accordance 
with earlier fi ndings showing that ET--in-
duced vasoconstriction leads to an increase in 
blood pressure but does not aff ect heart rate 
(Remuzzi , Gandhi ). Elevated ET- 
levels have been measured in several disease 
states with disturbed vascular control, e.g. 
Raynaud´s phenomenon, pulmonary hyper-
tension, and subarachnoid hemorrhage (Miller 
, Remuzzi , Gandhi ). Th ere may 
be several mechanisms underlying develop-
ment of high blood pressure pre- and postop-
eratively, and endothelin may be one of them. 
ET- antagonists are in clinical use in the treat-
ment of pulmonary hypertension and in phase 
III testing for the treatment of vasospasm aft er 
subarachnoid hemorrhage.
In this study, no statistical connection be-
tween ET- concentrations and development 
of cutaneous necrosis was found. Flap blood 
fl ow was not measured in Study III, but the de-
velopment of necrosis was observed clinically. 
One of the many factors causing cutaneous 
necrosis is intense vasoconstriction of the fl ap 
vessels, leading to decreased fl ap microcircula-
tion (Khouri ). ET- may be an important 
regulator of the fl ap blood fl ow, aff ecting the 
development of necrosis (Menger , Samu-
elson , Tane , Inoue , Pang , 
Mobley ). Studies on the eff ect of ET an-
tagonists on fl ap blood fl ow and development 
of necrosis have recently yielded promising re-
sults (Tane , Inoue , Erni , Wet-
tstein ). In our study, the small size of the 
patient group may have masked the connection 
between ET- and cutaneous necrosis. Future 
studies are needed to determine the relation of 
ET-, cutaneous blood fl ow, and development 
of necrosis in surgical fl aps. 
Th e blood samples for plasma ET- deter-
minations were drawn from the limb on which 
Tind and Tant probes were positioned. Th e el-
evated ET- levels observed before induction 
could be assumed to refl ect a considerable lo-
cal release of ET- from the same limb. ET- is 
a local hormone. Most of its release from the 
vascular endothelium is directed to the muscle 
layer of the vessel and not to the bloodstream. 
Circulating ET- levels are thought to greatly 
underestimate local concentrations (Wagner 
). Th e circulating half-life of ET- is only 
. minutes (Vierhapper ). Very small in-
travenous doses of synthetic ET- cause an in-
crease in forearm blood fl ow in humans. When 
the ET- dose increases, blood fl ow decreases 
as a result of an intense vasoconstriction of the 
small arteries and arterioles with a duration 
of at least two hours (Remuzzi , Gandhi 
). Vasoconstriction develops slowly, in 
– minutes, in segments of human mesen-
teric arteries (Miyauchi ). Fast pulmonary 
clearance for ET- has been observed in some 
animal models, but this has been questioned in 
humans (Gandhi ). 
Th e cause for the high ET- levels of the 
patient who was excluded remains obscure. 
Incorrectly high ET- values can be seen aft er 
incomplete lyophilization, which is unlikely in 
this case, since dozens of samples were handled 
simultaneously in the radioimmunoassay. He-
moglobin remaining in the sample may also 
lead to very high ET- values; however the 
method used of extraction removes all hemo-
globin from the sample.
6.4. Effect of felodipine on plasma 
ET-1 concentrations, peripheral va-
soconstriction, postoperative PtcO2, 
and survival of free TRAM fl aps (IV) 
Administration of calcium antagonists has 
suppressed ET- release and subsequent va-
soconstriction in experimental and clinical 
studies (Kiowski , Liu , Kobayashi 
, Yakubu ). Calcium antagonists have 
also reduced the incidence of necrosis of fl aps 
in some experimental studies (Hira , Pal 
, Yessenow , Bailet ), while having 
no eff ect in others (Miller , Emery ). 
Felodipine is a vasodilatory dihydropyridine 
calcium antagonist capable of relaxing arterial 
resistance vessels (Ljung ). Th eoretically, it 
might be able to decrease perioperative ET- 
levels and vasoconstriction and increase cuta-
neous blood fl ow in a fl ap. However, felodipine 
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had no eff ect on plasma ET- concentrations, 
Tgrad, or postoperative PtcO of free TRAM fl aps 
in this prospective, double-blind, and random-
ized study (IV).
In Study IV, the plasma ET- levels on the 
preoperative and postoperative days were quite 
high compared with levels in healthy humans at 
rest (,– pg/ml) (Karwatowska-Prokopczuk 
). Elevated ET- levels have been measured 
during major operations, e.g. heart surgery or 
gastrectomy (Shirakami ). Endothelin 
may play a role in the no-refl ow phenomenon 
seen in free fl aps and replanted digits (Lantieri 
). Breast reconstruction with a free TRAM 
fl ap is a time-consuming operation with a fairly 
long ischemia in the fl ap and extensive manip-
ulation of vessels during the preparation and 
performing of anastomoses. Stretch and isch-
emia are among factors increasing ET- release 
(Gandhi ). Th e stretch and manipulation 
of the recipient and fl ap vessels and ischemia of 
the fl ap before the anastomoses are completed 
might have induced marked local ET- release, 
seen as relatively high plasma ET- concentra-
tions in Study IV. 
In Study IV, the intraoperative and postop-
erative ET- concentrations were determined 
from arterial plasma. However, venous plasma 
ET- concentrations refl ect the actual levels in 
the tissues more accurately than arterial con-
centrations since ET- is released locally (Wag-
ner ) and the pulmonary clearance of ET- 
from plasma is very rapid (Gandhi ). Th e 
venous ET- concentrations have been found 
to be higher than arterial concentrations in 
healthy humans (Wagner ). Th e arterial 
ET- concentrations were measured in Study 
IV on the operation day because the aim was to 
determine out the ET- level in the blood fl ow-
ing to the fl ap. An eff ect of felodipine on ET- 
concentrations might have been observerd, if 
the ET- levels had been measured from the 
vein of the fl ap pedicle. Venous ET- concen-
trations would have given a clearer image of the 
actual amount of ET- release in the fl ap. Re-
cently, Lantieri and coworkers measured ET- 
concentrations from peripheral venous plasma 
and the venous blood running from the fl ap in 
 patients during breast reconstructions with 
free TRAM or DIEP fl aps. Th ey observed an 
increase in ET- concentration in the venous 
blood from the fl ap, but not in peripheral ve-
nous blood, aft er opening of the arterial anas-
tomosis. Th ey speculated that increased ET- 
level could be an explanation for the vasospasm 
seen in free fl aps (Lantieri ).
Tgrad has been shown to correlate well with 
volume plethysmography as a sign of peripheral 
blood fl ow (Rubinstein ). Th e degree of va-
sodilation judged by Tgrad was similar in the two 
study groups, although Tgrad tended to be lower 
in the felodipine group during the fi rst hour 
aft er the operation. A larger dose of felodipine 
possibly could have had a clearer vasodilatory 
eff ect. Th e dosage of oral felodipine,  mg at 
: hours and  mg eight hours later, was 
chosen based on the daily doses used for treat-
ment of hypertension (.– mg once daily). In 
unanesthetized healthy subjects,  mg of felo-
dipine causes an increase in forearm blood fl ow 
and a decrease in forearm peripheral resistance 
(Agner ). However, a dose of felodipine 
larger than the one used to treat of hypertension 
increases the risk of excessive tachycardia and 
hypotension. Despite its powerful vasodilatory 
capacity, felodipine may be no more eff ective 
than other calcium antagonists in preventing 
vasoconstriction under clinical circumstances 
resembling the ones of this study.
Th e given dose of felodipine was clinically 
eff ective based on the pre-induction HR, which 
was signifi cantly higher in the felodipine group 
than in the control group. Felodipine, with its 
vasodilating properties, caused a decrease in 
systemic vascular resistance in this study, based 
on the increase of HR and no changes in MAP. 
Felodipine had no eff ect on the pre-induction 
or on intraoperative MAP values. In healthy 
subjects, a single dose of felodipine increases 
resting HR (Agner , Carruthers ). 
In this study, HR during and aft er anesthesia 
stayed at a higher level in the felodipine group 
than in control patients, showing that the eff ect 
of felodipine continued up to the postoperative 
period. Th e highest MAP levels in both groups 
were measured  minutes and one hour aft er 
the patients had arrived in the recovery room. 
In healthy subjects, felodipine has no eff ect or 
only causes a minor decrease in mean resting 
blood pressure (Agner , Carruthers ). 
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Th e postoperative rise of blood pressure is part 
of the stress response induced by surgery (Hal-
ter ). According to this study, felodipine 
has a minor decreasing eff ect on postoperative 
blood pressure, probably because of its vasodi-
latory capacity. 
Felodipine and control groups did not diff er 
with regard to PtcO values or development of 
necrosis of the fl ap. Th is is in contrast to some 
experimental studies, where the incidence of 
necrosis was reduced by calcium antagonists 
(Hira , Pal , Yessenow , Bailet 
). In both groups of Study IV, two of the 
ten patients developed a minor cutaneous ne-
crosis on the contralateral side of the fl ap. Th is 
in consistent with the incidence of cutaneous 
necrosis reported in studies on free TRAM 
fl aps (Schusterman , Trabulsy , 
Chang , Kroll , Nahabedian b). 
Th e incidence of cutaneous necrosis is much 
higher in pedicled than free TRAM fl aps (Har-
trampf , Schusterman , Elliott , 
Kroll , Paige , Clugston , Garvey 
). Th e eff ect of felodipine might have been 
clearer had the study groups consisted of pa-
tients with pedicled instead of free TRAM 
fl aps. 
6.5. Effect of indices of obesity 
on cutaneous or fat necrosis in 
pedicled TRAM fl aps (V)
Cutaneous necrosis is a common complication 
in pedicled TRAM fl aps. It usually develops 
in the most distal contralateral part of the fl ap 
(zone IV). Surgical revisions are oft en needed 
to treat the necrotic area. Th ey increase costs, 
lengthen hospital stay, and cause physical and 
emotional distress to the patient. Overweight 
and obesity increase the risk of cutaneous ne-
crosis in pedicled TRAM fl aps according to 
several studies (Berrino , Moran , 
Ducic , Spear ), but one earlier study 
reported that obesity had no eff ect on inci-
dence of cutaneous necrosis (Kroll ). Fat 
necrosis has been observed in pedicled fl aps of 
obese patients more oft en than in patients with 
ideal weight (Berrino ). Obesity has been 
determined in those studies as BMI ≥  (kg/
m). Based on our results, BMI and cutaneous 
or fat necrosis do not seem to be associated. 
Th e small size of the patient group is, however, 
a limitation of the study. No patients had BMI 
> . Five of the  women were overweight 
(BMI ≥ ), and cutaneous of fat necrosis was 
observed in two of their fl aps. In a Finnish 
population study, .   of women aged  to 
 years and .   of women aged  years or 
more had BMI >    in – (Aromaa 
). Had our study group been larger, more 
patients likely would have been obese, and a 
connection might have emerged between BMI 
and cutaneous necrosis.
Th e eff ect of the type of body fat distribu-
tion on development of cutaneous necrosis 
has not been investigated earlier in TRAM 
fl aps. In this study, fi ve of  patients devel-
oped marginal cutaneous or fat necrosis on 
the contralateral side of pedicled TRAM fl aps. 
Th ere were no fl aps with necrosis in the pa-
tients with upper body type fat distribution 
(WHCR >  .). Upper body type (male type) 
obesity has been associated with cardiovascu-
lar problems (Lapidus , Björntorp , 
Kannel ) and increased peripheral vascu-
lar resistance (Jern ) in women. Increased 
peripheral resistance may be one contributing 
factor in development of partial necrosis in 
pedicled fl aps, so one would expect necrosis to 
be more common in patients with upper body 
type fat distribution. However, the results of 
this study contradict this hypothesis, instead 
suggesting an association between lower body 
type (female type) fat distribution and de-
velopment of marginal necrosis in pedicled 
TRAM fl aps. 
In pedicled TRAM fl aps, peripheral vascu-
lar resistance might not play a major role in 
development of marginal cutaneous or fat ne-
crosis. In women with lower body type fat dis-
tribution, the relative overweight in the lower 
abdomen likely stretches the perforators run-
ning through the rectus muscles, as suggested 
by Schefl an (Schefl an ). In such cases, the 
SEA cannot provide suffi  cient blood supply to 
the entire fl ap. One can also speculate that the 
fl ap area is too large to be perfused suffi  ciently 
in women with lower body type fat distribution. 
Th e exact size of the skin island of the TRAM 
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fl ap was not measured in this study, but the size 
of the TRAM fl ap was chosen to achieve the 
best possible symmetry with the other breast. 
Another explanation might be that the supe-
rior epigastric vessels are smaller in women 
with lower type body fat distribution. If this 
hypothesis proves to be correct, a free TRAM 
fl ap might be more suitable than a pedicled 
fl ap for breast reconstruction in women with 
lower body type obesity. Th e caliber of the su-
perior epigastric vessels could be established 
preoperatively with computed tomography 
angiography or intraoperatively with ICG an-
giography, and in the case of very thin vessels, 
the operation plan could be changed e.g. to a 
free TRAM fl ap
Th e amount of obesity can be estimated 
also by measuring the thickness of subcutane-
ous fat with ultrasound (Katch , Ramirez 
, Suzuki , Orphanidou ). Here, 
the mean thickness of abdominal fat increased 
during the fi rst week aft er the operation. It 
then stayed fairly unchanged throughout the 
nine-month study period. Th e initial increase 
of thickness probably resulted from edema in 
the immediate postoperative period and re-
modeling of the fl ap. Based on these fi ndings, 
the thickness of abdominal fat does not seem 
to be associated with cutaneous necrosis of 
pedicled TRAM fl aps. Recently, Yano and co-
workers measured the thickness of abdominal 
subcutaneous fat preoperatively in  pedicled 
TRAM fl aps. Th ree of their patients developed 
cutaneous necrosis and six fat necrosis of the 
fl ap. Th eir results showed that abdominal fat 
thickness is not a risk factor for necrosis in 
pedicled TRAM fl aps in patients who are thin, 
average, or mildly obese. Th eir fi ndings are in 
accordance with ours. Th ey also observed a 
close correlation between BMI and thickness 
of subcutaneous fat in the abdominal area 
(Yano ).
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. During breast reconstruction with a pedicled TRAM fl ap, elevation of 
the contralateral side of the fl ap causes an increase in cutaneous blood 
fl ow of the fl ap. When the DIEA is ligated, a decrease in cutaneous blood 
fl ow is observed with LDF and PtcO on the contralateral side of the fl ap, 
continuing on the postoperative days. Th e LDF and PtcO levels are lower on 
the contralateral side than on the ipsilateral side of the fl ap at all measuring 
times (I). 
 In a free TRAM fl ap, the intraoperative changes in cutaneous blood fl ow 
are similar to those in a pedicled fl ap. Th e postoperative blood fl ow in a 
free TRAM fl ap measured by PtcO and LDF is more generous than in a 
pedicled fl ap (II). 
. Development of cutaneous necrosis of a pedicled TRAM fl ap can be 
predicted based on intraoperative LDF measurements. Th e contralateral 
LDF value decreases to  ±    of the initial value aft er ligation of the DIEA 
in fl aps developing cutaneous necrosis during the next week. Cutaneous 
necrosis cannot be predicted based on intraoperative PtcO values (I).
. A correlation exists between the perioperative plasma ET- concentrations 
and the peripheral vasoconstriction, as well as between plasma ET- 
concentrations and MAP during and aft er a long plastic surgical operation. 
ET- levels are elevated in the recovery room. No association is present 
between ET- concentrations in systemic blood and development of 
cutaneous necrosis or HR in pedicled TRAM fl aps (III). 
. Felodipine, a vasodilating calcium channel blocker, has no eff ect on plasma 
ET- concentrations, peripheral vasoconstriction, postoperative PtcO, or 
development of cutaneous necrosis in free TRAM fl aps. Felodipine has a 
minor decreasing eff ect on postoperative blood pressure (IV).
. Neither BMI nor thickness of abdominal fat seems to be associated with 
the development of cutaneous or fat necrosis in pedicled TRAM fl aps. 
However, this study included no patients with BMI >. An association 
may exist between lower body type fat distribution and development of 
marginal necrosis in pedicled TRAM fl aps (V). 
7 Conclusions
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